Graduate Theses, Dissertations, and Problem Reports
2009

The role of NADPH oxidase in blood -brain barrier dysfunction
following stroke in aged rats
Kimberly Kelly
West Virginia University

Follow this and additional works at: https://researchrepository.wvu.edu/etd

Recommended Citation
Kelly, Kimberly, "The role of NADPH oxidase in blood -brain barrier dysfunction following stroke in aged
rats" (2009). Graduate Theses, Dissertations, and Problem Reports. 4482.
https://researchrepository.wvu.edu/etd/4482

This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research
Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license
in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses,
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU.
For more information, please contact researchrepository@mail.wvu.edu.

The Role of NADPH Oxidase in Blood-Brain Barrier Dysfunction
Following Stroke in Aged Rats

Kimberly Kelly

Dissertation submitted to the
School of Pharmacy
at West Virginia University
in partial fulfillment of the requirements
for the degree of

Doctor of Philosophy
in
Pharmaceutical and Pharmacological Sciences

Jason D. Huber, Ph.D., Chair
Charles Rosen, M.D., Ph.D.
James O’Callaghan, Ph.D.
Patrick Callery, Ph.D.
James O’Donnell, Ph.D.

Department of Basic Pharmaceutical Sciences

Morgantown, West Virginia
2009

Keywords: Blood-Brain Barrier, Middle Cerebral Artery Occlusion (MCAO),
NADPH oxidase (NOX), Apocynin

ABSTRACT

The Role of NADPH Oxidase in Blood-Brain Barrier Dysfunction
Following Stroke in Aged Rats

Kimberly Kelly

Stroke is the leading cause of long-term adult disability and the third leading cause of
death in the United States. More that 72% of stroke victims are over the age of 65, yet most
studies utilize young animals. Aged rats suffer exacerbated stroke volume and inflammation, as
well as worsened functional outcome when compared to young adult rats. While the blood brain
barrier (BBB) remains intact with age, it becomes more susceptible to external factors. BBB
permeability in the penumbra appears acutely, 20 min after middle cerebral artery occlusion
(MCAO) in aged rats. Importantly, BBB permeability is earlier and more severe in aged animals
and occurs before neuronal damage. Interestingly, our permeability studies using a small
vascular space marker indicated small, subtle, permeability changes in the contralateral
hemisphere. Permeability changes in the contralateral hemisphere were not found in young rats
and were not found in aged rats when using a large vascular space marker (Evan’s blue).
The free radical theory of aging contends that age-related diseases result from
accumulation of oxidative stress damage as a result of increased generation of reactive oxygen
species (ROS) and decreased antioxidant enzyme activity. Of particular interest are the
NADPH oxidases (NOX1, NOX2, and NOX4), which have been implicated as a damaging
source of ROS during the aging process. However, the role of NADPH oxidase isoforms during
the progression of cerebral ischemia in aged rats is poorly understood. Apocynin, a NOX2
inhibitor, reduces infarct volume, neuron death, activated microglia, and edema formation in
young rodents following brain injury. However, when administered to aged rats, apocynin
significantly increased mortality and edema formation. These results indicate an age-dependent
difference in the mechanism of action of apocynin.
Our studies demonstrate that aged rats have significantly worse strokes both in gross
size as well as structure as compared to young rats. Aged rats consistently have worsened and
prolonged functional impairment, exacerbated BBB permeability, increased neuronal damage,
and intensified inflammatory cell infiltration post MCAO and reperfusion when compared to
young adult rats. Importantly, BBB permeability and increased oxidative stress markers were
found in the contralateral hemisphere of aged rats after MCAO and reperfusion. These findings
provide evidence for a compensatory role of the contralateral hemisphere after stroke that can
only be studied in aged animals. Utilizing aged animals to study the mechanisms of brain injury
after MCAO and reperfusion is vital to finding clinically applicable therapies.
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Chapter One

Literature Review

1

Stroke is the leading cause of long-term adult disability and the third leading cause of death in
the United States. Over 750,000 individuals suffered a stroke in 2005 with mortality in 143,579
cases (Lloyd-Jones et al., 2009). Figure 1.1 depicts the incidence of stroke increasing
exponentially with age. In fact, approximately 72% of stroke victims are over 65 years of age
(Figure 1.1). Moreover, due to the longer life span of females stroke burden is actually greater
for women than men.
Age, in particular, has been identified as an independent predictor of outcome following
cerebral ischemia, influencing several aspects of stroke pathophysiology including blood brain
barrier (BBB) integrity. The BBB acts as a regulatory interface between the systemic circulation
and the brain parenchyma. Disruption of this critical barrier during cerebral ischemia is
associated with increased morbidity and mortality. Morphological changes in the BBB, which
occur during aging, make it more susceptible to injury.
The only FDA-approved therapy for ischemic stroke is the i.v. administration of tissue
plasminogen activator (tPA) which promotes thrombolysis of an embolic thrombus to reestablish
cerebral blood flow. However, indications for tPA administration are strict including a narrow
time window of opportunity, limitations due to risk of hemorrhage and implications of possible
neurotoxicity. Consequently, less than 5 percent of stroke patients receive i.v. tPA thrombolysis
treatment. After a decade of searching for neuroprotective agents to treat stroke, no clinically
applicable treatments have been approved. These failures may be attributed to the disregard
for two important variables: advanced age and blood-brain barrier integrity. Age is the largest
risk factor for stroke and has been largely ignored in experimental animal models of stroke. The
BBB preserves the neuronal microenvironment and thus protecting the integrity of this barrier
may lead to neuron viability.
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Stroke and Animal MCAO Models
As 87% of strokes are ischemic in nature, most stroke models utilize occlusion of the middle
cerebral artery (MCA) which results in reduced cerebral blood flow to the striatum and cortex
(Ponten et al., 1973; Garcia, 1984). Several types of MCA occlusion (MCAO) models exist that
produce either permanent (Tamura et al., 1981; Bederson et al., 1986) or transient (Longa et al.,
1989; Belayev et al., 1996) occlusion via chemical (Moyanova et al., 1998; Nikolova et al., 2009)
or physical (Badan I et al., 2003; Liu et al., 2009; Yao et al., 2003; Yao et al., 2009; DiNapoli VA
et al., 2006) approaches. Chemical occlusion consists of administration of endothelin-1 which
constricts the vessel to reduce blood flow (Moyanova et al., 1998; Nikolova et al., 2009).
Physical occlusion can be achieved by lifting the MCA with a tungsten hook (Badan I et al.,
2003), photothrombotic occlusion (Yao et al., 2003; Yao et al., 2009) or through the use of a
nylon suture to block the vessel (Liu et al., 2009).
A more appropriate model utilizes a blood clot to create an ischemic stroke, followed by
tPA administration to disrupt the clot and reperfuse tissue (Kudo et al., 1982;Kaneko et al.,
1985;DiNapoli VA et al., 2006). Several advantages of a fibrin clot model include: more realistic
reperfusion, ability to utilize thrombolytic therapy, and ability to screen for neuroprotectants that
are effective in concert with tPA. Investigations by well established research groups administer
to rodents a tPA dosage of 10-20 times the therapeutic dose for humans (0.9 mg/kg). At this
supratherapeutic dose tPA has been shown to increase edema (Armstead WM et al., 2006) and
excitoxicity (Parathath et al., 2006;Tsirka, 1997;Wang et al., 1998) which lead to neuron death.
Young adult male rats are most commonly used to study stroke. With the investigation
of the role of estrogen levels in stroke outcome, the use of young adult female rats has been
implemented with an ovariectomized group to study post-menopausal changes. However,
ovariectomy models only represent approximately 13% of women (Acosta et al., 2009).
3

Furthermore, a disparity exists with estrogen treatment where aged animals have worsened
stroke volume (Selvamani and Sohrabji, 2008; Rosen CL et al., 2005) and young adult females
have improved outcome (McCullough LD and Hurn PD, 2003).
Utilization of an embolic model of MCAO and tPA reperfusion in aged reproductively
senescent female rodents allows for the investigation of mechanisms underlying stroke
pathophysiology and effects of thrombolysis in a clinically relevant model.

Age & Stroke
Aging affects every organ system in the body, including the vasculature. These changes have a
compounding effect in relationship to deteriorated functional performance and increased
prevalence of chronic diseases. In the cerebral microcirculation, age is associated with
decreased elastin and collagen (Grunnet, 1969), increased tortuosity (Hassler, 1965; Akima et
al., 1986), and vascular thickening (Ay et al., 2005) causing impaired cerebral autoregulation.
The ability to react to and secrete neurotransmitters such as dopamine (Freeman and Gibson,
1987; Arai and Kinemuchi, 1988; Gerhardt et al., 2002), glutamate (Dawson, Jr. et al., 1989)
and nerve growth factor (Gomez-Pinilla et al., 1989) become altered in the aged brain.
Advanced age is associated with dysregulation of the nitric oxide/cyclic guanosine
monophosphate (NO/cGMP) pathway (Chalimoniuk and Strosznajder, 1998), which under
physiological conditions promotes angiogenesis, neurogenesis, axonal outgrowth, and synaptic
plasticity (Truman et al., 1996; Koyano-Nakagawa et al., 1999; Bredt and Snyder, 1994). In
agreement with this, aging has been correlated with decreased expression of VEGF and
impaired angiogenesis (Black et al., 1989; Rivard et al., 1999), as well as decreased
neurogenesis and neuronal progenitor cells (Kempermann et al., 1998; Kuhn et al., 1996).
Furthermore, aging is characterized by vulnerability to oxidative stress (Aliev et al., 2002; Li et
al., 2005b; Floyd and Hensley, 2000), excitotoxic damage (Wozniak et al., 1991; Wheeler and
4

Ondo, 1986), apoptotic events (Hiona and Leeuwenburgh, 2004) and traumatic injury (Hoane et
al., 2004) possibly causing the cortical atrophy seen with advanced age.
Age is a risk factor predicting worsened functional performance (Lindner et al., 2003)
and poor functional recovery (Rosen CL et al., 2005; Markus et al., 2005; Lindner et al., 2003;
Zhang et al., 2005; Zhao et al., 2005). Likewise, with every year of age, nearly a percent more
penumbral tissue turns to infarction (Ay et al., 2005). Age-related alterations in the
microvasculature appear to be the cause of poor neuron viability and increased mortality
associated with stroke (Rosen CL et al., 2005; Lindner et al., 2003; Zhang et al., 2005).

Structure and Function of the Blood-Brain Barrier
The BBB forms discrete microenvironments within the brain to support the optimal functioning of
a diverse array of neurotransmitters (Abbott, 1987). With over 20 m2 of surface area, BBB
endothelial cells serve as the physical interface between the systemic circulation and brain
parenchyma (Butt et al., 1990). The BBB is a semi-permeable membrane with unique
characteristics that confer distinct properties that differentiate the BBB from peripheral
capillaries, including a well-defined basement membrane, presence of tight junctions, absence
of fenestrations, and close apposition to other brain cell types, including pericytes, astrocytes,
microglia, and neurons (Hawkins et al., 2007a; Huber et al., 2001). Several reviews detail the
transport properties of the BBB as they pertain to both drug delivery and pathology (Ohtsuki and
Terasaki, 2007; Pardridge, 2007; Hawkins et al., 2007b; Persidsky et al., 2006; Pan and Kastin,
2004).
Once considered a static, rigid wall, the BBB is now considered a dynamic, complex
structure capable of rapid modulation and response to stimuli (Huber et al., 2001). The BBB is
able to maintain and regulate brain homeostasis and compensate for fluctuations in the
systemic circulation and increased metabolic functions within the brain as it functions like a
5

dynamic barrier. The active nature of the BBB also has important implications for the
development and progression of central nervous system diseases, including HIV encephalitis
(Toborek et al., 2003), meningitis (Winkler et al., 2001), multiple sclerosis (Plumb et al., 2002),
Alzheimer’s and Parkinson’s disease (Zlokovic, 2002;Ariga et al., 1998), epilepsy (Saija et al.,
1992), and stroke (Latour LL et al., 2004). Previous studies have shown that the BBB is
responsive to external stimuli and systemic-based diseases (Brooks et al., 2005;Witt et al.,
2003;Huber et al., 2002). Viewing the endothelium of the blood-brain barrier as part of a larger,
integrated functional unit (neurovascular unit) has opened up exciting avenues for translational
and collaborative research in which the blood-brain barrier is viewed as susceptible to pathology
and a potential therapeutic target.
A particularly unique aspect of BBB structure is the presence of tight junctions (Figure
1.2), which create a rate-limiting barrier to paracellular diffusion of solutes between adjacent
endothelial cells. The tight junction consists of the transmembrane proteins junctional adhesion
molecule, occludin, and claudins, linked via accessory proteins including zonula occludens
(ZO)-1 and -2 to the actin cytoskeleton. ZO-1 is a cytoskeletal scaffolding protein that recruits
the transmembrane proteins occludin and claudin-5. Occludin and claudin-5 homotypically bind
the adjacent endothelial cell to seal the paracellular pathway. Altered protein expression of
occludin and claudin reflect tight junctional changes indicative of increased paracellular
permeability. Claudin-5 is essential for tight junction formation and the decreased expression of
occludin at the cytoskeleton indicates increased permeability. The BBB possesses an
‘epithelial-like’ resistance (1500–2000 Ω*cm2) to paracellular diffusion, which helps to maintain
brain homeostasis (Crone and Christensen, 1981).
Tight junctions are dynamic structures, in which multiple signaling pathways and factors
regulate the expression, localization, and protein-protein interactions (Bazzoni and Dejana,
2004;Harhaj and Antonetti, 2004). Studies have shown that changes in total expression and
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subcellular localization of the tight junction proteins have been associated with alterations in
paracellular permeability (Huber et al., 2001) and may play an important role in communicating
the state of cell–cell contacts to the nucleus and participating in the regulation of growth,
differentiation, and gene expression (Matter et al., 2005).
Disruption of this critical barrier during cerebral ischemia is associated with increased
morbidity and mortality. The time course of BBB disruption during stroke and its role in ischemia
and reperfusion injury is poorly understood. Morphological changes in the BBB, which occur
with aging, make it more sensitive to insult. Activation of the barrier to ischemia is well studied;
however, the role of aging in altering the dynamic properties and functionality of the BBB has
direct implications for the majority of stroke victims.

The Inflammation and Free Radical Theories of Aging Combined
The free radical theory of aging (Harman D, 1994;Harman D, 1956) contends that as aging
progresses oxidative stress ensues due to accumulation of reactive substances as by-products
of metabolic processes and decreased activity of antioxidant enzymes. This theory has been
widely substantiated by findings of decreased antioxidant enzyme activity (Mayhan WG et al.,
2008;Abete P et al., 1999;Harvey BH and Nel A, 2003;Kolosova NG et al., 2006;Azhar S et al.,
1995;Carney JM et al., 1991;Azhar S et al., 1995;Reaven PD et al., 1999), increased reactive
oxygen species (ROS) (Hamilton CA et al., 2002;park L et al., 2007;Hamilton et al., 2001), and
accumulation of products of oxidative stress (Azhar S et al., 1995;Reaven PD et al.,
1999;Carney JM et al., 1991;Knight JA et al., 1987) with advanced age. Also, a species lifespan directly correlates to its ability to adapt to and neutralize ROS formation (Cutler RG, 1991).
Accumulation of ROS and reactive nitrogen species (RNS) correlates with increased
inflammatory processes (Chung et al., 2001;Reale et al., 2003;Rodriguez et al., 2007). Nuclear
factor kappa-light-chain-enhancer of activated B cells (NF-κB) responds to pro-oxidants by
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activating pro-inflammatory cytokine gene expression (Chung et al., 2001;Salvioli et al., 2006).
Likewise, the aging process correlates with a basal level of inflammation (Muller-Werdan,
2007;Krabbe et al., 2004;Perry et al., 2007). Known as the inflammatory hypothesis of aging,
increased age is associated with increased interleukin-6 (IL-6) (Miller and Cappuccio,
2007;Krabbe et al., 2004;Muller-Werdan, 2007;Chung et al., 2001), interferon-gamma (IFN-γ)
(Rodriguez et al., 2007;Chung et al., 2001), tumor necrosis factor-alpha (TNFα) (Rodriguez et
al., 2007;Krabbe et al., 2004;Siren et al., 1993;Chung et al., 2001), interleukin-1 (IL-1) (Chung et
al., 2001), and transforming growth factor beta (TGF-β) (Chung et al., 2001). The inflammation
hypothesis of aging has become a widely known theory into the relationship between the comorbidity of aging and neurodegenerative diseases (Chung et al., 2001;Muller-Werdan,
2007;Krabbe et al., 2004).
Pro-inflammatory cytokines can also induce formation of ROS (Madamanchi et al.,
2005). In particular, TNFα has been shown to modulate NADPH oxidase to increase ROS
production (Basuroy et al., 2008;St et al., 2008;Anilkumar N et al., 2008;Jung Y et al.,
2008;Guggilam et al., 2007;Chenevier-Gobeaux et al., 2006). Thus, a positive feedback loop of
inflammation and oxidative stress ensues. While the aging body is able to keep the basal
inflammation and oxidative stress under control under physiological conditions, an injury or
pathogen could disrupt the balance and exacerbate damage.

The Blood-Brian Barrier and Aging
BBB disruption plays a prominent role in the progression and onset of several
neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases, as a result of a
damaged endothelial barrier (Ariga et al., 1998). Increased transport of circulating amyloid beta
peptides across the BBB has been linked to increased age in nonhuman primates, potentially
leading to development of Alzheimer’s disease (Mackic et al., 2002). The BBB remains intact
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during aging; however, it becomes more susceptible to external factors. Changes in BBB
composition in aged animals include alterations in lipid and protein composition (Mooradian and
Smith, 1992;Mooradian, 1994), changes in nutrient transport (Shah and Mooradian, 1997), and
decreased reactivity to β-adrenergic neurotransmitters (Mooradian, 1994). Results have also
demonstrated changes in tight junction proteins with decreased occludin expression and
increased ZO-1 expression in 24 month old rats as compared to 3 and 12 month old rats
(Mooradian et al., 2003).
The BBB expresses efflux proteins responsible for preventing toxic substances that gain
entry into the brain from accumulating. Two such proteins are P-glycoprotein (P-gp) and
multidrug resistance associated protein (MRP). P-gp acts as an active efflux pump by shuttling
potentially toxic substances from the brain to the blood. Decreased P-gp expression has been
shown in Parkinson’s (Kortekaas et al., 2005;Bartels et al., 2008b) and Alzheimer’s diseases
(Cirrito et al., 2005). Aging has also been shown to decrease P-gp expression and function in
rodents (Matsuoka et al., 1999;Rosati et al., 2003;Tsai et al., 2002) and humans (Bartels et al.,
2008a).
Age affects several critical BBB parameters, and recent evidence suggests that altered
tight junction protein expression in aged rats could disrupt the functional and structural integrity
of the BBB. In a recent report, both ipsilateral and contralateral hemispheres of aged rats had
increased BBB permeability to sucrose (342 Da) 24 h after MCAO and reperfusion (Kelly et al.,
2009). Often in stroke studies utilizing young animals, the contralateral hemisphere is either
ignored or considered control. However, previous clinical studies have observed changes in the
contralateral hemisphere following stroke (Carey et al., 2002;Blank et al., 2003). These results
highlight a role for the contralateral hemisphere as a compensatory mechanism following stroke.
Utilizing aged rodents in stroke models provides a unique opportunity to gain a better
understanding of changes in the contralateral hemisphere following stroke.
9

The Neurovascular Unit
The periendothelial accessory structures of the BBB include pericytes, astrocytes, neurons and
a basal membrane. Pericytes can contribute to the regulation of endothelial cell proliferation,
survival, migration, differentiation and vascular branching (Hellstrom et al., 2001). Astrocytes
are glia that surround more than 99% of the BBB endothelium affecting its function and
morphology (Beck et al., 1984;Arthur et al., 1987). Astrocytes also serve as a scaffold for
neurons and microvessels during development. The basal lamina, lying between the capillaries
and the rest of the neurovascular unit, provides support for cell attachment and migration, as
well as preventing the passage of macromolecules into the brain parenchyma. Neuronal
involvement in the neurovascular unit remains unclear. However, the ability of the brain to
increase the blood supply to neuronally active areas suggests at least an indirect link between
the neurons and the BBB.
Glial cells, specifically astrocytes, are involved in BBB development and activation
during stress (Abbott, 1987). Transformation of astrocytes to the reactive phenotype is
characterized by increased expression of GFAP (glial fibrillary acidic protein) (Stoll et al., 1998)
which has been shown to be a biomarker of neuronal damage (O'Callaghan and Sriram, 2005).
Following cerebral ischemia there is increased expression of GFAP (Petito et al., 1990;Kindy et
al., 1992;Petito and Halaby, 1993). Constitutive expression of GFAP is increased in 24 month
old rodents, as well as 60-79 year old humans, in the cortex and hippocampus (Nichols et al.,
1993). Sex steroids (estrogen, testosterone, and dihydrotestosterone) have been implicated in
maintaining GFAP levels, the ramifications of this are a loss of plasticity correlated with aging
(Schroeder E et al., 2003;Sapolsky, 1992;Day et al., 1993). In aged animals, the astroglial and
microglial activation, along with glial scarring is abnormally accelerated in pathological
conditions (Popa-Wagner A et al., 2007;Badan I et al., 2003).
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Microglia exist in two forms: ramified and reactive. Ramified microglia are present in the
brain throughout life, while reactive microglia are found during nervous system damage (Giulian
and Baker, 1986;Lin et al., 1998). Following ischemic onset, microglia become activated within
minutes (Gehrmann et al., 1995;Gehrmann et al., 1992;Banati et al., 1993) with peak activation
at 2 weeks (Lin et al., 1998). Microglia can release cytokines, chemokines and other neurotoxic
agents which can cause inflammation and exacerbate injury. However, microglia are also
responsible for scavenging cellular debris and releasing growth factors (Sriram and
O'Callaghan, 2005). In aged animals microglia become activated faster in response to stroke
than young adult animals (Popa-Wagner A et al., 2007;Badan I et al., 2003).

Reactive Oxygen Species & Reactive Nitrogen Species
Schematic representation of reactive oxygen and nitrogen species generation and breakdown
appears in Figure 1.3. Superoxide (O2-) is formed by NADPH oxidases. Superoxide is normally
converted by superoxide dismutase (SOD) into H2O2. When pathological conditions cause
increased superoxide concentration (either by increased production or decreased metabolism) it
reacts with nitric oxide (NO.) to form peroxynitrite (ONOO-).
Hydrogen peroxide is thought to be mainly produced by the breakdown of superoxide by
SOD. However, NOX4 containing NADPH oxidase, xanthine oxidase, and glucose oxidase also
produce hydrogen peroxide (Martyn KD et al., 2006;Ruiz-Gines JA et al., 2000;Cai H, 2005).
Catalase and glutathione peroxidase reduce hydrogen peroxide into water and molecular
oxygen. Under pathological conditions, H2O2 production can overwhelm these enzymes.
Hydrogen peroxide can spontaneously form hydroxyl radical or can react with myeloperoxidase
(MPO) to produce hypochlorous acid (HOCl) or nitrogen dioxide radical (NO2.) which can cause
nitratrion of tyrosines (3-NO2.-Tyr) (Miller AA et al., 2006).
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The effects of ROS on cerebral microvasculature
The direct effects of superoxide on the vasculature have not been clearly defined, but many
speculate that the effects are concentration dependent (Miller AA et al., 2006). When
superoxide is produced in excess, it reacts with the vasodilator nitric oxide, decreasing its
bioavailability and therefore possibly causing vasoconstriction. Peroxynitrite formation
inactivates Mn-SOD (Guo W et al., 2003), and leads to peroxidation of lipids, protein oxidation
and DNA damage (Chan PH, 2001).
Hydrogen peroxide has been shown to cause cerebral vasodilation (Iida Y and Katusic
ZS, 2000;Paravicini et al., 2004;Wei EP et al., 1996;Yang ZW et al., 1998b;You J et al., 2005).
Dilation can also be caused by amelioration of contractions by angiotensin II (Miller AA et al.,
2005). Hypochlorous acid (HOCl) can oxidize low-density lipoproteins (LDLs) which then get
taken up by macrophages, build up in atherosclerotic plaques, and react with proteins to inhibit
the synthesis of nitric oxide (Zhang C et al., 2003). The 3-nitrotyrosine (3-NO2.-Tyr) produced
by the reaction of nitrogen dioxide radicals with tyrosine residues can lead to impaired protein
catalysis and dysregulated tyrosine kinase pathways, as phosphorylation of tyrosine is
prevented by nitrogen dioxide (Bigelow DJ, 2008).
Hydrogen peroxide has been shown to dose-dependently increase permeability (Kahles
T et al., 2007). Hydroxyl radical, being highly reactive, can damage nuclei and cell membranes
which can directly impact the integrity of the BBB (Bonomini F et al., 2008). Peroxynitrite
exposure has been shown to decrease claudin-5 content (Haorah et al., 2005). ROS have also
been shown to redistribute occludin (Schreibelt et al., 2007;Lee et al., 2004) and ZO-1 (Lee et
al., 2004). The changes in these tight junction proteins cause dysregulation of the BBB allowing
paracellular diffusion and therefore disruption of the homeostasis of the brain parenchyma.
With most studies of BBB functional integrity looking at Evan’s blue extravasation, it is not
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surprising that few studies show changes in permeability. The passage of Evan’s blue bound to
albumin into the brain parenchyma marks the entry of a 65,000 dalton molecule past the BBB.
As the barrier is physiologically able to prevent passage of molecules more than 200 times
smaller than albumin, the extravasation of evan’s blue into the brain marks irreparable damage
to the integrity of the BBB. The use of small vascular space markers, i.e. sucrose (342 daltons),
allows investigation of small, possibly reparable, damage to the BBB, or alternately controlled
areas in the integrity.

NADPH Oxidases
Several isoforms of NADPH oxidases are expressed in vascular cells. While the NOX2 isoform
is widely considered the predominant isoform, it is the least expressed isoform in the brain
vasculature. In the brain vasculature, NADPH oxidase isoform expression varies with NOX1
being the most abundant, followed by NOX4 and lastly NOX2 (Ago et al., 2005). The NOX1
isoform of NADPH oxidase consists of an enzymatic subunit which complexes with p22phox.
Cytosolic subunits NOX organizer 1 (NoxO1) and NOX activator 1 (NoxA1) are required for
activation of NOX1 (Takeya R et al., 2003). Conversely, the NOX4 isoform does not require
activation by recruitment of cytosolic subunits and is thus constitutively active (Martyn KD et al.,
2006). The NOX2 isoform consists of a membrane bound enzymatic subunit (gp91phox)
complexed with p22phox. Phosphorylation of p47phox recruits the complex of p47phox,
p67phox and rac to the membrane, activating NOX2 (Bedard K and Krause K, 2007). Both
NOX1 and NOX2 isoforms require activation to produce superoxide. However, the NOX4
isoform constitutively produces hydrogen peroxide (H2O2) (Martyn KD et al., 2006).
NOX2 is widely considered the isoform of NADPH oxidase to cause oxidative damage
after cerebral ischemia (Kahles T et al., 2007;Tang et al., 2007;Wang Q et al., 2006). However,
in several studies NOX2 has been shown to be unchanged not only between the genders (Miller
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AA et al., 2007) despite a well known difference in stroke risk between women and men, but
also in saphenous veins following heart failure (Dworakowski R et al., 2008). In basilar arteries
NOX1 mRNA expression is 2.4 fold higher in males than in females (Miller AA et al., 2007)
which correlates to the higher stroke risk in men when compared to pre-menopausal women.
The role of NOX1 in stroke pathology has yet to be studied. In vitro studies have shown
upregulated NOX4 after serum deprivation (Lassegue et al., 2001). In vivo, permanent
occlusion of the MCA resulted in increased NOX4 mRNA at 24 h (Vallet P et al., 2005;Badan I
et al., 2003) whereas transient occlusion resulted in increased NOX4 at 6 h but not 24 h
(McCann SK et al., 2008). NOX4 was also found to be upregulated in the contralateral
hemisphere 24 h post-MCAO (Badan I et al., 2003). Finally, NOX4 was increased in the
saphenous veins following heart failure compared to healthy controls (Dworakowski R et al.,
2008). While NOX1 and NOX4 have been largely ignored in stroke research, evidence
suggests they play an important role in the progression of ischemic damage.

Modulation of NADPH oxidases
Inhibition of NOX2 with apocynin has recently gained momentum as a therapeutic option for
treatment of acute ischemic stroke (Tang et al., 2007;Wang Q et al., 2006;Kahles T et al., 2007)
as studies demonstrate that administration of apocynin (5-50 mg/kg; i.p.) in young rodents prior
to MCAO, attenuated superoxide production, infarct volume (Tang et al., 2007), neuronal death,
activation of microglia (Wang Q et al., 2006) and edema formation (Kahles T et al., 2007).
In non-phagocytic cell culture, apocynin is not an inhibitor of NADPH oxidase (Heumuller
S et al., 2008). However, apocynin has been extensively used as a selective inhibitor of
NADPH oxidase in studies utilizing both in vitro and in vivo methodologies. Apocynin is
activated by oxidation by peroxidases into products that have higher efficiencies with faster
initiation of NADPH oxidase inhibition (Johnson et al., 2002). The oxidation of apocynin forms a
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radical (Kanegae et al., 2007). Two of these radicals can form a apocynin dimer which can also
be oxidized by myeloperoxidase and bind to a radical to become a trimer (Ximenes et al., 2007).
The mechanism of NADPH oxidase inhibition by apocynin is thought to be the interaction of
apocynin with a thiol group on the membrane bound subunit of NADPH oxidase which then
prevents the recruitment of the cytosolic subunits and therefore prevents superoxide production
(Stefanska and Pawliczak, 2008). Apocynin, as well as the dimer and trimer, were found to be
incapable of binding GSH (thiol group) (Ximenes et al., 2007). The radical and dimer radical,
however, did react with GSH (Ximenes et al., 2007). Thus the radical forms of apocynin are
probably the inhibitors of NADPH oxidase.
In pathologic inflammatory conditions, MPO is elevated (Tsimikas, 2008). In particular,
aged animals exhibit exacerbated inflammatory cell infiltration (DiNapoli VA et al., 2008) and
worsened stroke volume, which produces increased MPO expression (Romanos et al., 2007).
The positive correlation between MPO expression and apocynin activation suggests enhanced
NOX2 inhibition with age. Data gathered from young animals suggest that increased NOX2
inhibition results in a favorable outcome. In direct contrast, our data show that aged rats exhibit
exacerbated edema formation and increased mortality (Kelly et al., 2009). We conclude that
inhibition of NOX2 exacerbates stroke injury in the aged rat and would be a poor choice for
clinical treatment of stroke.
Plumbagin is a specific inhibitor of NOX4 (Ding et al., 2005). It has been shown to have
anti-carcinogenic (Ahmad et al., 2008;Kuo et al., 2006;Thasni et al., 2008), anti-atherosclerotic
(Sharma I et al., 1991) and anti-thromboembolic effects (Shen Z et al., 2003). In a study
utilizing cholesterol fed rabbits, subsequent oral dosing of plumbagin reduced LDL cholesterol,
increased HDL cholesterol, and decreased plaque formation on the aortic wall (Sharma I et al.,
1991). In breast cancer cells, decreased estrogen receptor signaling increases NF-κB
expression (Ahmad et al., 2008). NF-κB promotes cell survival by inducing Bcl-2 (an anti15

apoptotic gene) (Wang et al., 2007) and upregulating the PI3K/AKT pathway (promotes
autophagic cell death). Plumbagin has been shown to inhibit the activation of NF-κB caused by
TNF, IL-1β, okadaic acid, LPS, H2O2, phorbol myristate acetate, and cigarette smoke (Sandur et
al., 2006). Also, TNFα induced COX-2, MMP-9 and VEGF were attenuated with plumbagin
treatment (Sandur et al., 2006). To date, plumbagin has not been studied in ischemia.
Angiotensin II (ANGII) can be actively metabolized in the cerebromicrovasulature (Zhou
et al., 2006). Recent evidence suggests that ANGII provides the link between synaptic activity
and blood flow, also known as functional hyperemia (Kazama K et al., 2004). ANGII has been
shown to increase the expression of gp91phox (Imanishi et al., 2005), and the effects of ANGII
can be reversed by ROS scavengers (Kazama K et al., 2004;Didion and Faraci, 2003), NADPH
oxidase inhibitors (apocynin and gp91ds-tat) (Kazama K et al., 2004;Rodriguez-Pallares et al.,
2008;Didion and Faraci, 2003;Pendergrass et al., 2009) and the use of gp91phox-null mice
(Kazama K et al., 2004). Also, administration of AT1 (angiotensin II receptor subtype 1)
antagonists prevents the increased ROS associated with increased ANGII (Rodriguez-Pallares
et al., 2008;Imanishi et al., 2005). Animal models of cerebral ischemia have shown that
administration of AT1 receptor antagonists reduce the expression of NADPH oxidase, decrease
lipid peroxidation, improve functional outcome and reduce stroke volume (Kusaka I et al.,
2004;Faure et al., 2008). However, the use of ACE (angiotensin converting enzyme) inhibitors
or AT2 (ANGII receptor subtype 2) receptor antagonists have been shown to worsen ischemic
damage (Faure et al., 2008;Dalmay et al., 2001;Li et al., 2005a), suggesting the effects of ANGII
acting at non-AT1 receptors is neuroprotective. In patients receiving AT1 receptor antagonists
for treatment of hypertension, a meta-analysis found a 13% reduction in cardiovascular
morbidity and mortality which included cardiovascular death, stroke, and myocardial infarction
(Thomas et al., 2006).
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Matrix Metalloproteinases and Tissue Plasminogen Activator
Tissue plasminogen activator (tPA) is the only FDA approved treatment of ischemic stroke. The
object of tPA treatment is to break up the clot and reperfuse the tissue affected by the occlusion.
While tPA does effectively lyse blood clots, its effectiveness is questioned due to the increased
risk of hemorrhage and deleterious effects on the neurovascular unit associated with its use.
However, at a dose of 5 mg/kg i.v., administered 2 h post MCAO, tPA decreases BBB
permeability in both young adult and aged rats 24 h after embolic MCAO (DiNapoli VA et al.,
2008). Furthermore, a recent study utilizing EEIIMD (a hexapeptide that binds non-thrombolytic
sites on tPA) provides evidence that while some cortical damage could be due to nonthrombolytic actions of tPA; largely, striatal and total stroke volume are not exacerbated by tPA
(Tan et al., 2009).
During physiological conditions tPA is produced endogenously in the CNS during
learning of complex motor tasks (Harris-White and Frautschy, 2005). Extracellular matrix
remodeling, vascular permeability and excitotoxicity are some of the deleterious effects of tPA
that most likely occur during pathological increase in tPA production (Harris-White and
Frautschy, 2005;Yepes et al., 2003). tPA is a ligand for low density lipoprotein receptor-related
protein (LRP). Recently, the relationship between tPA and LRP has been implicated in the
permeability of the BBB after an ischemic injury (An et al., 2008). Both tPA (Yepes et al., 2003)
and LRP (An et al., 2008) are upregulated after ischemic insult and inhibition of LRP (An et al.,
2008) decreases edema formation. Specifically, tPA binds to LRP to phosphorylate Akt which
activates NF-κB and increases the expression of MMP-9 (An et al., 2008;Wang et al.,
2003b;Herz and Strickland, 2001).
Matrix metalloproteinases (MMPs) are a family of Ca2+ or Zn2+ containing
endopeptidases that have three similar structural domains: an aminoterminal propeptide, a
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catalytic metal-containing domain and a hemopexin-like domain at the carboxy-terminal end. A
subtype of MMPs is known as the gelatinases (MMP-2 and MMP-9) which are specialized for
degrading basement membrane (i.e. laminin and hepran sulfate proteoglycans) and
extracellular matrix (i.e. collagen IV and fibronectin) proteins (Uemura et al., 2001;Thrailkill et
al., 2007). Under physiological conditions, expression of MMPs remains low. However, MMP
expression can be upregulated by reactive oxygen species (Shin MH et al., 2008;Haorah et al.,
2007;Gasche et al., 2001). During pathologies that involve increased oxidative stress, such as
stroke, MMP-2 and MMP-9 can become upregulated (Nagel S et al., 2007;Gasche et al., 2001).
The fact that tPA upregulates MMP-9 is widely accepted (Tsuji et al., 2005;Montaner et
al., 2001b;Wang et al., 2003b;Sumii and Lo, 2002;Cuadrado et al., 2008). The actions of tPA
and MMP-9 are implicated in the hemorrhagic transformation that casts risk onto the use of tPA
as a stroke treatment. Over 24 h, administration of tPA is associated with a time and dose
dependent increase in active MMP-9 (Wang et al., 2003b). Inhibition of MMPs attenuated
incidence of tPA induced cerebral hemorrhage (Sumii and Lo, 2002). In a model of focal
cerebral ischemia MMP inhibitors reduced hemorrhage and improved functional outcome after
tPA administration (Tsuji et al., 2005).
MMP-9 is elevated after stroke (Zhao et al., 2006;Tsuji et al., 2005;Yepes et al.,
2003;Montaner et al., 2001b;Montaner et al., 2001a;Wang et al., 2003b;Gidday JM et al.,
2005;Sumii and Lo, 2002;Clark et al., 1997;Cuadrado et al., 2008;Gu et al., 2002) by the actions
of inflammatory cytokines (Akool et al., 2003;Rosenberg et al., 1995;Jian and Rosenberg,
2005;Harkness et al., 2000;Zhou et al., 2009) and free radicals (Jian and Rosenberg,
2005;Akool et al., 2003;Tsuji et al., 2005;Haorah et al., 2007;Gu et al., 2002). As early as 4
hours (Gasche et al., 2001) and from 1 to 3 d post-cerebral ischemia MMP-9 is increased in the
endothelial cells of the ischemic striatum and cortex (Zhao et al., 2006;Montaner et al.,
2001a;Jian and Rosenberg, 2005;Wang et al., 2003b;Gidday JM et al., 2005;Clark et al., 1997).
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At later time points, 7 to 14 d, MMP-9 is increased in the penumbral neurons and astrocytes
(Zhao et al., 2006). MMP-2, while constitutively active, becomes upregulated several months
after stroke (Montaner et al., 2001a;Clark et al., 1997). Levels of MMP-2 are increased in
patients with previous history of stroke (Montaner et al., 2001a). Increased MMP-9 is
associated with worsened neurological outcome (Montaner et al., 2001a), activation of
macrophages (Haorah et al., 2007), degradation of BBB substrates (Tsuji et al.,
2005;Rosenberg et al., 1995;Haorah et al., 2007;Gidday JM et al., 2005;Asahi et al., 2001;Van
and Libert, 2007;Gu et al., 2002) and BBB permeability (Rosenberg et al., 1995;Haorah et al.,
2007;Montaner et al., 2001b;Gidday JM et al., 2005;Asahi et al., 2001), increased inflammatory
cell infiltration (Tsuji et al., 2005;Rosenberg et al., 1995;Montaner et al., 2001a), parenchymal
damage (Tsuji et al., 2005;Gidday JM et al., 2005), edema formation (Tsuji et al., 2005;Haorah
et al., 2007;Montaner et al., 2001b;Gidday JM et al., 2005) and hemorrhage (Montaner et al.,
2001b;Lee et al., 2007) after cerebral ischemia.
Use of MMP knockout mice caused decreased BBB degradation (Yepes et al., 2003),
specifically attenuation of ZO-1 degradation (Asahi et al., 2001) after brain injury. MMP
inhibitors have decreased capillary permeability (Rosenberg et al., 1995) and hemorrhage (Lee
et al., 2007) after cerebral ischemia. Finally, treatment with MMP-9 siRNA 60 min after MCAO
resulted in significant reduction in mortality, infarct volume, edema formation, and functional
outcome (Hu et al., 2009). It has been suggested that MMPs could be a possible therapeutic
target (Hu et al., 2009) or surrogate marker for stroke damage (Montaner et al., 2001a). This
may be possible if focusing on MMP-9 at early time points. However, MMP-2 is associated with
angiogenesis (Rosenberg et al., 1995) and MMPs in general have been shown to be active in
tissue repair (Jian and Rosenberg, 2005). Due to the beneficial effect of MMPs at late time
points, more investigation into a safe time window for inhibition is necessary.
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CONCLUSION
As promising neuroprotectants screened in animal models fail to translate into clinically relevant
stroke therapies, the need for better models becomes increasingly imperative. In this review of
the current literature we have discussed the role of aging and the blood-brain barrier in stroke
pathophysiology. Age is the largest risk factor for stroke; yet, an overwhelming majority of
animal models continue to utilize young adult animals to understand the mechanisms and find
therapies for cerebral ischemia. Results from models utilizing aged animals are increasingly
divergent from those in young adult animals. This disparity suggests that age is an important
and yet overlooked variable in the study of stroke mechanism and the search for clinically
applicable therapies.
Blood-brain barrier functional and structural integrity is extremely important to
maintaining the microenvironment of the brain. Studies have focused on gross breakdown of
BBB functional integrity. Utilizing small vascular space markers has allowed fine changes in
BBB dysregulation to be elucidated. Investigation of subtle changes in BBB functional and
structural integrity will give better insight into the time frame and mechanism of the
pathophysiology of ischemic damage.
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Figure 1.1 Stroke Prevalence by age and sex (Lloyd-Jones et al., 2009)).
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Figure 1.2 Schematic representation of intercellular junction between two endothelial cells.
Cerebral endothelial cells possess cadherins, JAM, and tight junctions. However, the tight
junction provides the cerebral endothelium with its unique phenotype. Zona occludens serve
as the cytoskeletal scaffolding for the transmembrane proteins claudin-5 and occluden, which
forms the cell-to-cell junction. Claudin 5 is essential for tight junction formation. Occluden
exists as a cytosolic or plasma membrane protein and location within the cell reflect changes
in paracellular permeability (Huber et al., 2001).
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Figure 1.3. Mechanisms of formation and breakdown of reactive oxygen species. Schematic
modified from Miller et al., 2006. (Miller AA et al., 2006).
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Chapter Two

Early disruptions of the blood-brain barrier may contribute to
exacerbated neuronal damage and prolonged functional recovery
following stroke in aged rats

This work has been published in Neurobiology Aging (2008);29(5):753-64.
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ABSTRACT
We examined the effects of age on stroke progression and outcome in order to explore the
association between blood-brain barrier (BBB) disruption, neuronal damage, and functional
recovery. Using middle cerebral artery occlusion (MCAO), young (3 months) and aged (18
months) rats were assessed for BBB disruption at 20 min post-MCAO, and 24 h post-MCAO
with tissue plasminogen activator induced reperfusion at 120 min. In addition, young and aged
rats were assayed for functional recovery out to 14 d post-MCAO and reperfusion. Results
showed that BBB disruptions in aged rats occurred early and increased nearly two-fold at both
the 20 min and 24 h time points when compared to young animals. Neuronal damage in aged
rats was increased two-fold as compared to young rats at 24 h, and differed qualitatively in the
degree of inflammatory cell infiltration, hemorrhage and edema. No difference in neuronal
damage was observed between young and aged rats at 20 min. Young and aged rats exhibited
neurological deficits when compared to sham-controls out to 14 d following MCAO and
reperfusion; however, aged rats exhibited more severe onset of deficits and prolonged recovery.
Results indicate that aged rats suffer larger infarcts with increased BBB disruption, greater
neuronal damage, and reduced functional recovery. Moreover, BBB disruption at 20 min postMCAO in aged rats, in the absence of significant neuronal damage, suggests a potential
mechanism by which alteration in BBB functional integrity during stroke contributes to a greater
degree of subsequent neuronal injury.
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INTRODUCTION
Stroke is a disease of the elderly. Approximately 72% of people who suffer a stroke are over the
age of 65, 25% of the population over the age of 75 will have a stroke, and the incidence of
stroke more than doubles with each successive decade for people over the age of 55 (LloydJones et al., 2009). Increased infarction volumes and altered physiologic response has been
demonstrated in aged rodents following middle cerebral artery occlusion (MCAO) (Rosen CL et
al., 2005; Sutherland et al., 1996; DiNapoli VA et al., 2006). Young male animals and
filamentous methods of occlusion commonly utilized in laboratory investigations may not
accurately represent the stroke patient, as these methods have consistently identified promising
neuroprotective candidates that have failed in clinical trials (Gladstone DJ et al., 2002;Fisher,
1999; Fisher and Ratan, 2003).
The disparity between laboratory models and clinical studies may be secondary to
changes which occur in the blood-brain barrier (BBB). A number of morphological and functional
changes to the BBB occur during the aging process, including remodeling of the extracellular
matrix, decreased occludin expression, changes in lipid and protein composition (Burns EM et
al., 1981; Mooradian AD, 1988; Mooradian and Meredith, 1992; Mooradian and Smith, 1992),
alterations in nutrient and protein transport (Shah GN and Mooradian AD, 1997;Banks and
Kastin, 1985; Kleine et al., 1993), and decreased reactivity to β-adrenergic neurotransmission
(Mooradian, 1994). These alterations make the barrier more vulnerable to insult, such as
ischemia. Cessation of cerebral blood flow and the subsequent lack of tissue oxygenation can
lead to increased BBB permeability by a progressive loss of component antigens from the basal
lamina and extracellular matrix, as well as alterations in endothelial cell-cell and cell-matrix
interactions. The active hypoxia/ischemia induced following a stroke stimulates the surface
expression of adhesion molecules (Haring et al., 1996; Mao et al., 2000) and changes in integrin
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expression (Wagener et al., 1997) in the first few hours. Activation of the BBB leads to
endothelial dysfunction, characterized by increased permeability, extravasation of plasma
components, and edema formation (Okada et al., 1996). What effect aging has in this process
and how it may affect stroke outcome are not well characterized.
We utilized a clinically relevant model of stroke, based upon selective embolization of
the middle cerebral artery (MCA) combined with recombinant tissue plasminogen activator (rtPA) induced reperfusion, and assessed tissue loss, functional outcomes, histopathology and
changes in BBB permeability in young (3 mo.) and aged (18 mo.) Sprague-Dawley rats. Our
data demonstrated that the BBB in aged animals is disrupted earlier and to a greater degree
compared to young animals at 24 h post-MCAO and rt-PA treatment, and 20 min post-MCAO.
Aged rats suffer strokes which are larger in size and have more severe functional
consequences, providing a potential mechanism by which accelerated breakdown of the BBB
during acute stroke leads to worsened outcomes.
MATERIALS AND METHODS
Animals
This study was conducted in accordance with NIH guidelines for the care and use of animals in
research. All protocols were approved by the West Virginia University Animal Care and Use
Committee. Three groups of female, age-matched, Sprague-Dawley rats were investigated.
Young (3-4 months; n=68), and aged (17-18 months; n=77) animals underwent an embolic
middle cerebral artery occlusion (MCAO).
Surgical Procedure for MCAO
Rats were anesthetized with an intraperitoneal injection of 2.5 mg/kg flunixine, 90 mg/kg
ketamine and 5 mg/kg xylazine, or with inhaled isoflurane (4% induction; 1% maintenance) for
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BBB objectives. A servo-controlled homeothermic heating blanket, utilizing a rectal
thermometer, was used to maintain body temperature at 37ºC. A cartridge based arterial blood
gas machine (GEM Premier 3000, Instrumentation Laboratory, Lexington MA) was used to
monitor arterial PaO2, PaCO2, pH and hematocrit. Blood from the femoral artery was analyzed just
prior to embolization, during ischemia, and following recanalization. The femoral vein was
catheterized for fluid replacement (1.4 ml/h 0.9% saline) and drug delivery.
Rats underwent selective embolization of the right middle cerebral artery (MCA),
producing 120 min of ischemia, followed by rt-PA induced reperfusion utilizing a technique
recently described (DiNapoli VA et al., 2006). Briefly, a microcatheter, outer diameter 0.3 mm,
was inserted into the ICA via the ECA stump and advanced until its tip occluded the ipsilateral
MCA. This mechanical occlusion was verified by laser Doppler (LD-CBF) monitoring of the MCA
perfusion territory. The catheter was retracted until MCA flow was restored around the
microcatheter. A 25 mm fibrin-rich, autologous blood clot was then injected directly into the
MCA. Ischemia was monitored continuously for 120 min, rt-PA was administered via the femoral
vein, and restoration of MCA flow was verified by LD-CBF.
Functional Testing
Rats were handled and habituated to testing procedures in order to establish stable baselines
on all measures. Animals were then tested repeatedly in a battery of functional assessments
described below, beginning 24 h post-MCAO or sham operation and continuing daily for 1 week.
Animals were then allowed to recover for an additional week and final assessments made at
14d post-insult. Scores were obtained by an observer blind to treatment of subject in order to
reduce bias.
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Composite Functional Score. The mNSS is a composite score of motor, sensory,
balance and reflex measures and ranges from 1 to 17, with higher scores indicating greater
neurological injury (Chen J et al., 2001; Germano et al., 1994; Seyfried et al., 2004).
Bracing. Postural adjustments were assessed according to methods previously reported
(Schallert et al., 1979). Animals were gently pushed laterally across a stainless steel bench top
over a distance of 90 cm, at a rate of approximately 20 cm/s, by the experimenter's hand. Rats
will generally adjust their posture, making numerous adjustments with their forelimb on the side
to which they are being moved. These adjustments were tallied over two trials and analyzed.
Placing. This is a test of sensorimotor function previously reported to be effected by
normal aging in rodents (Marshall, 1982). Animal were held suspended by the investigator,
allowing free movement of the unsupported limbs. The animals were then brought to the edge of
a bench top, such that its body was parallel to the table's edge its whiskers brushed against the
top surface. The number of times the animal successfully raised its forelimb to the table top was
tallied over a series of 10 trials for each forelimb.
Tactile adhesive-removal test. Somatosensory function was tested as previously
reported (Schallert et al., 1982; Schallert et al., 1983). A small adhesive paper circle ("Color
Coding Labels", 1/4 inch in diameter, ACCO brands, Lincolnshire, IL) was placed on the distalradius area of each forelimb and placed back in cage. The time taken for the animals to remove
to stimulus with its mouth was recorded over a series of three trials, with an inter-trial interval of
1-2 min, and a maximum trial length of 180 s. The means from three trials were analyzed.
Akinesia test. This test assesses the animal's ability to initiate movements with the
paretic forelimb (Schallert et al., 1992). The rat was held by the experimenter such that one
forelimb was allowed to rest on the table top and move freely. The number of steps taken with
the limb over a 30 s trial was tallied for each forelimb.
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TTC staining
Animals were allowed to recover 24 h following MCAO and rt-PA reperfusion, anesthetized with
Sleepaway (Fort Dodge Animal Health), and the brains were removed immediately and sliced
coronally at 2 mm intervals. Slices were placed in 2%-2,3,5-triphenyltetrazolium chloride (VWR
International, West Chester PA) in 0.1 M PBS for 20 min at 37ºC, scanned on a flatbed scanner
and analyzed using Adobe Photoshop software (v7.0). Infarction volumes were determined
according to the methods described by Yang et al (Yang ZW et al., 1998a).
Tissue collection for frozen sections
Animals were allowed to recover for designated period, anesthetized with Sleepaway (Fort
Dodge Animal Health), and trancardially perfused with 100 ml of 0.09% saline followed by
perfusion solution (4.0% w/v paraformaldehyde in 1X SPB). Brains were removed, placed in
fixative for 24 h, cryoprotected in a series of 10, 20 and 30% sucrose w/v in DPBS solution for
24 h per solution and sectioned at 35 µm.
Hematoxylin and eosin staining. Slide-mounted sections from three sham-controls and
three randomly selected animals in each age group 24 h post-MCAO and rt-PA reperfusion,
were rehydrated in DPBS for 5 min, and incubated in hematoxylin and eosin (Fischer Scientific)
stain for 5 min at room temperature. Sections were rinsed for 5 min in running tap water and
dehydrated for 5 min each in 75%, 95% and 100% ethanol, cleared in xylene, and coverslipped
with Permount (Fischer Scientific). Sections were taken serially at 250 µm intervals, and
examined utilizing light microscopy for areas of polymorphoneutrophil infiltration, hemorrhage
and edema.
Fluoro-Jade B staining. Slide-mounted sections from three sham-controls and three
randomly selected animals in each age group 24 h post-MCAO and rt-PA reperfusion were
stained with Fuoro-Jade B. Slides were immersed in a solution of 1% sodium hydroxide in 80%
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ethanol for 5 min, followed by immersion in 70% ethanol for 2 min, and distilled water for 2 min.
The slides were transferred to 0.06% potassium permanganate for 10 min on a shaker to
suppress background staining. Following a rinse in distilled water for 2 min, the slides were
transferred to the staining solution for 20 min (stock FJB solution: 10 mg dye in 100ml distilled
water; 0.004% working solution: 4 ml stock solution in 96 ml 0.1% acetic acid). The slides were
washed three times for 1 min each in distilled water, and air-dried overnight. The slides were
coverslipped directly with DPX (Fisher Scientific)
Confocal Microscopy
At 23 h following MCAO and rt-PA administration, 1 mg each of lysine fixable dextran (70,000
Da; AlexaFlour 488) and fibrinogen (300,000 Da; AlexaFlour 568) dissolved in 0.5 ml of 0.9%
saline were injected into the femoral vein. After 1 h, rats were anesthetized and transcardially
perfused with 0.9% saline for 5 min then 4% paraformaldehyde/ 0.1 M sodium cacodylate buffer
(pH 7.2). For 20 min assessments, fluorescent markers were injected 40 min prior to clot
injection and animals were perfused, as stated above, 20 min post-MCAO. Following perfusion,
brains were removed and post fixed in 4% paraformaldehyde overnight. Areas around infarction
were cut into 4 mm blocks, sliced into 60 μm sections, and assessed for fluorescent activity
using a Zeiss LSM 510 confocal microscope and analyzed using Optimas analysis system.
Evans blue albumin extravasation
Albumin extravasation was quantified 24 h following MCAO and rt-PA reperfusion. Rats were
anesthetized with 2.5mg/kg flunixine, 90 mg/kg ketamine and 5 mg/kg xylazine and the infused
with 2% Evans blue (4 ml/kg) via the femoral artery. The Evan's blue was allowed to circulate for
1 h and the rats were perfused with cold phosphate buffered saline (pH 7.4) for 15 min via the
left ventricle. The brains were excised; meninges and ependymal organs removed,
hemispheres excised, separated, weighed, and homogenized in 500 µl of 50% trichloroacetic
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acid. The tissue was incubated for 24 h at 37ºC, and then centrifuged at 13,000 X g for 10 min.
The supernatants were diluted four-fold with absolute ethanol; fluorescence intensity was
measured using a fluorometer at 620 nm excitation, 680 nm emission (Beckman DU 640).
Calculations were based on external standard readings and extravasated dye was expressed as
ng EB/mg brain tissue.
Statistical Analysis
Data and figures are presented as means ± SE. Physiologic parameters and functional data
were compared by two-way ANOVA with groups of age (young and aged) by treatment (pre- or
post-stroke), followed by Tukey’s post-hoc evaluation. Infarction volumes and EB data were
compared by one-way ANOVA. Post-hoc t-tests were performed as directed by ANOVA
outcomes. P<0.05 was considered statistically significant.
RESULTS
Physiologic Variables
Physiologic data for groups subjected to MCAO are presented in Table 2.1. Significant
differences between groups were not observed, and values are within normal physiologic
ranges.
Mortality
Aged animals exhibited a 33% mortality rate at 24 h post-MCAO and rt-PA reperfusion with 12
of 36 animals dying during the first day of recovery, young animals suffered 17% mortality (5 of
29). In the group receiving MCAO only, 4 of 9 aged animals and 2 of 7 young animals died
during the 24 h recovery period. There were no deaths amongst sham-operated animals or prior
to 20 min sacrifice. The final analyses included 42 sham-operated controls, 65 rats with 120 min
MCAO and rt-PA reperfusion, 16 rats with 120 min MCAO and 22 rats with 20 min MCAO.
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Tissue loss is exacerbated in aged animals
Infarction volumes were significantly affected by animal age in both the cortical (F[2,27]=8.5,
P=0.001) and striatal (F[2,27]=6.9, P=0.004) regions, 24 h following 120 min MCAO and rt-PA
induced reperfusion (Figure 2.1, C). The percentage of infarcted cortex relative to contralateral
hemisphere was significantly higher in the aged (Figure 2.1, B) group (63±9%) when compared
to the young (Figure 2.1, A) (26±6%, P=0.002). Striatal infarction volumes were also significantly
greater in the aged group (53±5%) relative to the young (33±4%, P=0.006).
Increased hemorrhage and infiltration of inflammatory cells into the infarct is observed in
aged animals
At 24 h following MCAO and rt-PA reperfusion, brains from three animals in both age groups
were harvested for pathological examination. Figure 2.2 displays representative
photomicrographs (H&E) of slices from a young and aged rat. In the young animal (Figure 2.2,
A), a central area of coagulation necrosis is evident. This area contains sparse aggregates of
acute inflammatory cells (PMNs). Penumbra contains swollen neurons, some with vacuolated
neuropil. In the aged animal (Figure 2.2, B), the area of coagulation necrosis is partially
obscured by dense inflammatory cell infiltration and petechial hemorrhages. Increased
vacuolation of the neuropil is evident.
Functional deficits are more severe with prolonged recovery in aged animals
All animals were assessed for gross neurologic competence after awakening from anesthesia.
Behavioral deficits were grossly apparent in both age groups throughout the 14 d testing period,
with the persistence of circling in 4 of 10 young animals and all aged animals. Impairment in
normal feeding and grooming behavior was observed by 1 day post-MCAO. A red Harderian
gland secretion surrounding the eyes and nostrils was present in most animals during the initial
48-72 h period, indicating significant stress following the insult. Feeding and grooming behavior
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returned in all young animals by 7 d following MCAO, however, 4 of the 10 aged animals
remained severely impaired until time of sacrifice.
Consistent with gross observations, behavioral assays detected significant functional
impairment compared to baseline in both the young and aged animals throughout the recovery
period (Figure 2.3). Animals were tested for neurological competence utilizing the modified
neurologic severity scale (mNSS) (Chen J et al., 2001), sham-operated animals are represented
as day 0. ANOVA demonstrated a significant effect of age on functional severity of stroke
(F[2,27]=17.07, P<0.001) (Figure 2.3, A), with elevated mNSS scores correlating to increased
severity of functional impairment.
Results of the bracing test showed a significant effect of treatment on performance of
both young and aged rats throughout the 14 d testing period (F[8,72]=5.83, P<0.001) (Figure
2.3, B). Additionally, age had a significant affect on performance (F[1,72]=223.06, P<0.001).
Sham-controls in the aged group (10.4±0.6) demonstrated decreased baseline performance
when compared to young sham-controls (13.6±0.24) (P<0.01).
Results of the placing test showed a significant effect of treatment on performance of
both young and aged rats throughout the 14 d testing period (F[8,72]=24.69, P<0.001) (Figure
2.3, C). Additionally, age had a significant affect on performance (F[1,72]=933.11, P<0.001).
Young animals fully recovered in this task by day 14, with a peak deficit of 8.6±0.74
responses/10 trials. Aged animals recovered to a mean of 4.4 responses/10 trails by day 14,
with a peak deficit of 0 responses on days 1-3.
Results of the tactile removal test showed a significant effect of treatment on
performance of both young and aged rats throughout the 14 d testing period (F[8,72]=22.64,
P<0.001) (Figure 2.3, D). Additionally, age had a significant affect on performance
(F[1,72]=13.2, P<0.001). Young animals showed significant recovery in this task by day 7 with a
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mean removal time of 96.3±29.6 s, and a peak deficit of 170.6±9.3 s on day 1. Aged animals did
not show meaningful recovery.
Results of the akinesia test showed a significant effect of treatment on performance of
both young and aged rats throughout the 14 d testing period (F[8,72]=21.5, P<0.001) (Figure
2.3, E). Additionally, age had a significant affect on performance (F[1,72]=98.8, P<0.001).
Young animals showed moderate recovery in this task by day 14 with a mean of 26±2.7 steps, a
baseline of 43.6±0.9 and a peak deficit of 16.4±3.3 steps on day 1. Aged animals did not show
meaningful recovery with a mean of 10.6±1.3 steps on day 14, a baseline of 40.4±1.9 and a
peak deficit of 7±1.6 steps on day 1.
BBB permeability 24h post-MCAO is two-fold greater in the aged brain
BBB permeability in young and aged rats was assessed at 24 h post-MCAO by quantifying
extravasation of albumin (Figure 2.4, A) and visualization of fluorescent vascular markers by
confocal microscopy (Figure 2.4, B frames 3-6). Administration of rt-PA (5 mg/kg) at 2 h after
MCAO significantly (p<0.01) reduced albumin extravasation in infarcted hemispheres of both
young and aged rats at 24 h post-MCAO (Figure 2.4, A). Aged animals demonstrated a 212%
increase in BBB permeability to albumin in the infarcted hemisphere as compared to young
animals at 24 h post-MCAO and rt-PA reperfusion (Figure 2.4, A; p<0.01). No significant
(p>0.05) difference in albumin extravasation at the BBB was noted between contralateral
hemispheres of young and aged rats (Figure 2.4, A) nor in comparing contralateral hemispheres
of young and aged rats to age-matched sham control hemispheres (data not shown).
Figure 2.4 B (frames 3-6) depict a visualization of cerebral microvessels in an area
adjacent to the infarct (penumbra) of young (frame 3) and aged (frames 4-6) rats at 24 h postMCAO and rt-PA reperfusion using two vascular space markers (dextran-70 kDa and
fibrinogen-300 kDa). Frame 3 shows fibrinogen outlining the circuitous pattern of microvessels
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with no apparent detection of dextran in the microvessels or extracellular space. Frame 4 shows
fibrinogen outlining microvessels and the appearance of punctate regions of dextran in the
extracellular space. Frame 6 is a brightfield image that clearly shows fibrinogen
immunofluorescence is confined to the luminal side of the microvasculature and dextran is
found only in the extracellular fluid. Frame 5 is an image of the contralateral side of an aged rat
24 h post-MCAO and rt-PA reperfusion.
Functional disturbance of the BBB by 20 min post-MCAO
BBB permeability in young and aged rats was assessed at 20min post-MCAO by quantifying
extravasation of albumin (Figure 2.5, A) and visualization of fluorescent vascular markers by
confocal microscopy (Figure 2.5, B frames 3 and 4). Aged animals demonstrated a 175%
increase in BBB permeability to albumin in the infarcted hemisphere as compared to young
animals at 20 min post-MCAO (Figure 2.5, A; p<0.001). No significant (p>0.05) difference in
albumin extravasation at the BBB was noted between contralateral hemispheres of young and
aged rats (Figure 2.5, A) or in comparing contralateral hemispheres of young and aged rats to
age-matched sham control hemispheres (data not shown).
Figure 2.5 B (frames 3 and 4) depict a visualization of cerebral microvessels in an area
adjacent to the infarct of young (Frame 3) and aged (Frames 4) rats at 20 min post-MCAO using
two vascular space markers (dextran-70 kDa and fibrinogen-300 kDa). Frame 3 shows
fibrinogen outlining the microvessels with no apparent detection of dextran in the microvessels
or extracellular space. Frame 4 shows fibrinogen outlining microvessels and the appearance of
dextran in the surrounding extracellular space. No difference in dextran extravasation was
noted between contralateral hemispheres of young and aged rats or in comparing contralateral
hemispheres of young and aged rats to age-matched sham control hemispheres (data not
shown).
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Neuronal damage is preceded by BBB disruption
Neuronal damage in young and aged rats was assessed at 24 h post-MCAO and rt-PA
reperfusion (Figure 2.4, B frames 1 and 2) and 20 min post-MCAO (Figure 2.5B frames 1 and 2)
by Fluoro-Jade B staining. Aged (Figure 2.4, B frame 1) animals demonstrated increased
severity of injury, characterized by increased density and intensity of staining, as well as a
greater degree of vacuolation compared to young (Figure 2.4,B frame 1) rats. The transition
from severe neuronal injury within the MCA distribution to survival within the penumbra can be
observed.
No difference in intensity of staining was seen between aged (Figure 2.5, B frame 1) and
young (Figure 2.4, B frame 2) animals at 20 min post-MCAO. Early neuronal damage could not
be revealed utilizing the Fluoro-Jade B staining technique in the young or aged animals.
DISCUSSION
We demonstrated that aged rats suffered more severe infarcts with increased disruption of the
BBB, a greater degree of neuronal damage, and reduced functional recovery following MCAO.
In addition, we found that rt-PA (5 mg/kg) induced reperfusion at 120 min post-MCAO produced
a significant decrease in disruption of the BBB to albumin in young and aged animals at 24 h
following MCAO. Finally, we report data that suggests BBB disruption occurs prior to observable
neuronal damage during MCAO; thus, suggesting a potential mechanism by which alterations in
BBB functional integrity during stroke contribute to the degree of subsequent neuronal damage.
A primary concern of this study was the use of rt-PA in rodents. Prior investigations have
administered an rt-PA dosage 10-20 times the therapeutic dose for humans. A primary reason
for this discrepancy in dose was that rt-PA is produced by human recombinant DNA, and
species variations decrease rt-PA efficacy in rodents. In humans, rt-PA is administered at a
dosage of 0.9 mg/kg and has a narrow therapeutic window. Since introduction in 1995, rt-PA
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has remained the only approved method of drug induced thrombolysis for acute ischemic stroke
(1995). These breakthroughs have been hindered by unwanted consequences of rt-PA
treatment, most prominently the increased risk of hemorrhagic transformation and neurotoxicity
(1995;Jiang et al., 2003).
Successful and reproducible thrombolysis was achieved in rodents at half the rt-PA dose
which is commonly administered, limiting the deleterious effects. The drug was only
administered according to NIH suggested guidelines, and both young and aged rats were
routinely screened for intracranial hemorrhage following administration (DiNapoli VA et al.,
2006). Young and aged rats underwent 120 min of stable MCA occlusion, followed by
administration of rt-PA for recanalization. Duration of occlusion and successful reperfusion of
the MCA territory was verified by laser Doppler; furthermore, the reperfusion profile was similar
to that seen in a clinical setting. Previous studies have reported mortality rates (up to 80%)
amongst aged animals receiving 60-120 minutes of filamentous occlusion, which would
preclude further use in MCAO models (Futrell et al., 1991;Hachinski et al., 1992;Wang et al.,
1995;Wang et al., 2003a). This model produced a 33% mortality rate in the aged animals.
Administration of rt-PA at 120 min post-occlusion resulted in significantly decreased disruption
of the BBB and reduced mortality in both young and aged animals.
Studies have produced varied results concerning the effect of age on stroke outcome. In
comparison to young rats, the aged rats in this study showed nearly a two-fold increase in
infarction volume. The principal difference in infarction size can be attributed to larger
involvement of the cortical brain region in aged animals. The current study produced larger
infarctions volumes in all age groups and brain regions, compared to suture occlusion (Rosen
CL et al., 2005). In addition, histopathology of the infarcted region in aged animals distinctly
revealed advanced vacuolation of the neuropil, increased infiltration of polymorphoneutrophils
and pettichial hemorrhaging not seen in younger animals. These findings demonstrate that
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cerebral ischemia in aged rodents creates infarcts which are structurally different than those
generated by equivalent insults in younger animals.
The intact BBB has negligible transport of albumin into the brain; however, susceptibility
of the BBB has been documented in a number of diseases. Evidence has suggested that a
damaged endothelial barrier results in BBB disruption contributing to the progression and onset
of several neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases (Ariga
et al., 1998; Mackic et al., 2002). Under homeostatic conditions, the BBB remains functionally
intact during aging (Mooradian AD, 1988); however, becomes more susceptible to disruption by
external factors with increasing age (Daniel et al., 1978; Burns EM et al., 1981; Shah and
Mooradian, 1997).
In this study, we measured Evan's blue albumin extravasation into the brain parenchyma
of infarcted and non-infarcted hemispheres in young and aged rats at 20 min and 24h postMCAO, and 24 h post-MCAO with rt-PA induced reperfusion. Young and aged rats exhibited a
significant increase in BBB permeability to albumin 24 h post-MCAO and rt-PA reperfusion, and
this disruption was two-fold greater in the aged compared to the young rats. Confocal
microscopy confirmed leakage of albumin sized molecules across the BBB in aged animals.
Microscopy demonstrated extravasation of dextran (70 kDa) in an area adjacent to, but not
within, the infarct of aged animals. The failure to observe dextran in the penumbral region of the
infarct in young rats suggests that the BBB is still functionally intact. Fluoro-Jade B staining
assessed the degree of neuronal injury present, and demonstrated grossly observable damage
within the MCA fed territory of young and aged animals. In addition, the aged rats exhibited
increased intensity of staining within injured neurons, as well as vacuolation of the neuropil in
agreement with histopathology.

39

A significant increase in albumin extravasation was also noted at 20 min post-MCAO in
both age groups. The disruption in aged animals was again nearly 2-fold that seen in the young
group and was greater than 3-fold that observed in the contralateral hemisphere. Confocal
microscopy demonstrated the presence of dextran (70 kDa) in the extracellular space
surrounding the MCA perfusion territory at 20 min post-MCAO in aged rats, while Fluoro-Jade B
staining did not reveal neuronal injury at this time point. These data demonstrate a functional
alteration in the barrier's ability to maintain a separation between systemic circulation and the
brain parenchyma, ultimately contributing to cytotoxic changes in the extracellular environment.
The presence of this disruption preceding observable neuronal injury suggests that exacerbated
breakdown of the BBB in aged rats during acute stroke may contribute to the worsened
outcomes observed. Furthermore, it may be important to consider the stabilization of the barrier
in investigating new therapeutic interventions for stroke.
Evaluation of functional impairment has become a prominent focus in development of
preclinical models, as results gained can be correlated to subsequent clinical assessment in
stroke victims. Inclusion of aged animals in long-term functional assays has proven problematic
due to impractically high mortality rates. Previous reports have addressed this issue by creating
an incomplete filamentous occlusion, limiting the amount of tissue loss and lowering long term
mortality in the aged animals to approximately 24% (Lindner et al., 2003). Their experiments
produced long-lasting functional deficits amongst the aged rats, and allowed for functional
evaluation in the aged group (age 16 months) out to 90 days post-occlusion. This approach
certainly provides a compliment to the traditional use of young animals, which show less initial
deficit and recover more quickly; however, the previously mentioned shortcomings of
filamentous occlusion remain, as well as the inability to study rt-PA reperfusion and infarctions
representative of larger strokes.
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In utilizing functional assessments previously reported (Lindner et al., 2003), the current
study examined functional deficits in young and aged animals following 120 min embolic MCAO
and rt-PA induced reperfusion. Functional deficits seen in young animals were very similar to
previous reports, showing a moderate initial deficit followed by significant recovery over a two
week period. Aged animals in this study, however, showed severe initial deficits, with a dense
and profound paresis of the limbs on the affected side and significantly poorer performance on a
battery of functional challenges. Additionally, aged animals never exhibited functional
competence equivalent to the young animals at any time point and recovery was prolonged.
Thus aged rats had a functional status very similar to that seen clinically in patients having
suffered a stroke.
The need for an accurate preclinical MCAO model that mimics the stroke population and
allows for effective, reliable reperfusion is imperative for the successful translation of therapeutic
strategies and improved stroke outcomes. Hope for potential neuroprotective agents has
spurred intense research interest in basic science investigation and clinical trials, yet no
effective agent has been found. This study clearly demonstrated that age has a profound
influence on acute brain damage and subsequent functional recovery following an MCAO and
rt-PA reperfusion. These data further the consensus that stroke models should be developed in
older animals, and that use of aged animals in preclinical models may increase their clinical
relevance and predictive validity (Millikan, 1992). To our knowledge, this is the first study to
report reproducible reductions in MCA flow using an embolic technique, with consistent rt-PA
induced reperfusion and acceptable mortality rates in aged animals. Additionally, we begin to
explore the role of the aging BBB and how alterations to this structure during acute stroke affect
outcome. Early disruption of the BBB in aged animals during stroke provides a mechanism by
which this breakdown contributes to subsequent neuronal damage, and is a critical element to
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consider in the development and implementation of effective therapeutic strategies for treatment
of elderly stroke victims.
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Figure 2.1. TTC stained sections representative of young (A) and age (B) infarction distribution
24 h post-MCAO and rt-PA reperfusion. C, Volumetric analysis of cerebral infarctions. Infarction
volumes are expressed as a percentage of the contralateral structure ± SE. * Significant
difference in 18 month vs. 3 month age group (P≤0.006). N=10 for all groups.
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Figure 2.2. Representative photomicrographs of slices from young (A) and aged (B) animals,
24 h post-MCAO and rt-PA treatment. In the young rats (A), a central area of coagulation
necrosis is evident (closed arrowhead). This area contains sparse aggregates of acute
inflammatory cells (*) (PMNs). The margin of the infarct contains swollen neurons, some with
vacuolated neuropil (arrow). In the aged animals (B), the area of coagulation necrosis (closed
arrowhead) is partially obscured by dense inflammatory cell infiltration (*) and petechial
hemorrhages (open arrowhead). Vacuolation of the neuropil is evident (arrow) (Scale bar = 100
μm).
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Figure 2.3. Performance on functional tests performed from 1-14 d post-occlusion to access
neurological deficit. A, mNSS, A composite functional score, judged on a scale of 0 to 17 with
higher scores correlating to increased severity of functional deficits (N=10/group). B, Bracing
test reflects number of postural adjustments made by the animals while being pushed laterally
toward the paretic side over 90 cm (N=5/group). C, Placing test reflects the number of directed
paw placements made in response to somatomotor stimulus over 10 trials (N=5/group). D,
Tactile removal test reflects the time taken for animal to remove somatosensory stimulus placed
on distal forearm (N=5/group). E, Akinesia test reflects the number of steps made with usable
forearm over 30 s trial (N=5/group). Scores are means±SE.
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Figure 2.4
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Figure 2.4. A, Extravasation of albumin across the BBB assessed by quantification of Evan's
blue dye 24 h post-MCAO. Aged group untreated and treated with rt-PA exhibited greater BBB
permeability in relation to corresponding young animals and contralateral hemisphere (*,
P<0.01) (N=5). B, Photomicrographs of Fluoro-Jade B stained sections from a young (frame 1)
and aged (frame 2) animals 24 h post-MCAO and rt-PA reperfusion. Damaged neurons within
the infarcted region are fluorescently stained (green), while surviving neurons within the
pneumbra are left unstained (Scale bar = 100 μm). Frames 3-6, Confocal microscopy of
vascular permeability markers dextran (70 kDa) and fibrinogen (300 kDa) 24 h post-MCAO and
rt-PA reperfusion, taken in the penumbral region of the infarct. Frames 3 and 4, Confocal
images of fibrinogen (red) and dextran (green) reactivity in the ipsilateral cortex of young (frame
3) and aged (frame 4) animals. No dextran extravasation is observed in the young animal
(frame 3) and is similar to images from contralateral hemisphere of the aged animal (frame 5).
Dextran is present in the extracellular space of aged (frame 4) animals at the same time point.
Panel 6, Image in bright field that depicts lumen of cerebral microvessel. Fibrinogen can be
seen remaining within the lumen of the vessel, while dextran reactivity is present along the outer
surface in an aged animal that underwent MCAO and rt-PA reperfusion. (Scale bar = 5 μm)
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Figure 2.5
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Figure 2.5. A, Extravasation of albumin across the BBB assessed by quantification of Evan's
blue dye 20 min post-MCAO. Aged group exhibited greater BBB permeability in relation to
corresponding young animals and the contralateral hemisphere (*) (P<0.001). B,
Photomicrographs of Fluoro-Jade B stained section from a young (frame 1) and aged (frame 2)
animal 20 min post-MCAO. Damaged neurons were not observed within the MCA perfusion
territory in either young or aged animals (Scale bar = 100 μm). Frames 3 and 4, Confocal
images of fibrinogen (red) and dextran (green) reactivity in the ipsilateral cortex of young (frame
3) and aged (frame 4) animals, taken in the penumbral region of the infarct. No dextran
extravasation is appreciated in the young rats (3) and is similar to images from contralateral
hemisphere of the aged rats (not shown). Dextran is present in the extracellular space of aged
(4) animals at the same time point. (Scale bar = 5 μm)
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Supplemental Figure 2.1. All animals experienced an equivalent reduction and restoration of
cerebral blood flow. Laser Doppler cerebral blood flow (LD-CBF) was monitored throughout the
experiment. Chart represents mean percentage of baseline LD-CBF values±SE, at equivalent
time points, throughout the experiment. There are no significant differences between the means
at any time point. The 3 month old group demonstrated a higher LD-CBF with initial reperfusion
than the aged animals (time point 7); however, this difference was not significant (P=0.41).
(N=10)
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Table 2.1. Summary of Physiological Values Pre-, During and Post-Middle
Cerebral Artery Occlusion.

Groups

PaCO2

PaO2

pH

(mm Hg)

(mm Hg)

% Hct

MAP

7.44±0.07

32±8.1

109±6.8

36±3.2

80±7.8

Young
Pre (10)
During (10)
Post (10)

89±11.5
7.39±0.05

37±4.9

97±5.3

35±3.3

102±18.1

7.43±0.07

34±6.8

114±7.3

34±2.5

84±13.7

Aged
Pre (10)
During (10)
Post (10)

79±13.0
7.41±0.03

32±9.6

116±6.3

32±3.9

98±19.5
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Chapter Three

NOX2 inhibition with apocynin worsens stroke outcome in aged rats.

This work was published in Brain Research (2009) 1292:165-72.
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ABSTRACT
Background and Purpose: This study utilized middle cerebral artery occlusion (MCAO) with
tissue plasminogen activator (tPA) to assess inhibition of the NOX2 isoform of NADPH oxidase
on brain injury and functional recovery in aged rats.
Methods: Effects of NOX2 on the degree of brain injury and functional recovery following
MCAO and tPA reperfusion was assessed in young adult and aged rats. Rats received apocynin
(NOX2 inhibitor; 5 mg/kg) or saline 30 min prior to MCAO. At 24 h following MCAO, blood-brain
barrier permeability (BBB), stroke infarct volume, edema formation, and oxidative damage were
measured.
Results: Apocynin treatment in aged rats increased mortality rate and failed to improve
functional outcome, total infarct volume, edema formation, and BBB permeability. Aged rats
displayed increased BBB permeability to sucrose in the contralateral hemisphere following
MCAO and diminished antioxidant capacity in the brain as compared to young adult rats.
Conclusions: We conclude that inhibition of NOX2 in the aged rat exacerbates stroke injury and
diminishes functional outcome. These results suggest age is an important factor in stroke
damage and more rigorous examination of apocynin as a therapeutic agent for treatment of
stroke must be done.
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Introduction
NADPH oxidases are a damaging source of reactive oxygen species during the aging process
(Park L et al., 2007; Hamilton CA et al., 2001). Inhibition of the NOX2 isoform of NADPH
oxidase reduces superoxide formation (Tang et al., 2007), prevents oxidative damage in the
vasculature (Godbole et al., 2009; Park et al., 2008), and was recently touted as a promising
therapeutic target for treatment of stroke (Kahles T et al., 2007). Studies using embolic models
of stroke have identified many neuroprotective agents; however, none of these drugs have
improved stroke outcome in humans (Gladstone DJ et al., 2002). Most preclinical studies have
been conducted in young rodents. We contend that aging impacts brain damage and functional
recovery following stroke and that by not focusing on age-related processes, a vast area of
potential therapeutic growth has been overlooked. This study utilized middle cerebral artery
occlusion (MCAO) with tissue plasminogen activator (tPA) reperfusion to assess inhibition of
NOX2 on brain injury and functional recovery in aged rats. Our results demonstrated that age is
an important factor in stroke damage and suggest more rigorous examination of NOX2
inhibition as a therapeutic strategy for treatment of acute ischemic stroke is needed.
EXPERIMENTAL PROCEDURE
MCAO and Apocynin Treatment
Female rats were used in this investigation due to the exaggerated sexual dimorphism of size
and weight in young adult versus aged males. Female Sprague-Dawley rats [(3-4 months, 260280 g, n=92) and (18-20 months, 275-350 g, n=120)] were received from Harlan (Indianapolis,
IN) and housed under natural light/dark conditions with food and water available ad libitum.
Procedures involving animals abided by the West Virginia University Animal Care and Use
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Committee. Before MCAO or sham surgery, rats from both age groups were randomly divided
into apocynin (5 mg/kg; i.p.) and vehicle (0.9% saline; i.p.) treated groups. Treatment was
administered 30 min prior to surgery. Rats were anesthetized with ketamine (90 mg/kg; i.p.;
Webster Veterinary; Sterling, MA) and xylazine (5 mg/kg; Webster Veterinary) prior to surgery
and then supplemented as needed. Rats underwent MCAO for 2 h followed by tPA (Genentech;
San Francisco, CA)-induced reperfusion as previously described (DiNapoli VA et al., 2006).
Briefly, a micro-catheter was inserted into the internal carotid artery (ICA) and advanced until its
tip occluded the ipsilateral MCA. This mechanical occlusion was verified by laser Doppler (LDCBF) monitoring of the cerebral blood flow in the MCA perfusion territory. A 25 mm fibrin-rich,
autologous blood clot was then injected directly into the MCA. Sham surgery consisted of all
steps above except for occlusion of the MCA. Ischemia was monitored continuously. At 2 h,
tPA (5 mg/kg) was administered via the femoral vein, and restoration of blood flow through the
MCA was verified by LD-CBF. Ischemia was defined as a perfusion drop across the MCA
territory of >80% as determined by laser Doppler and successful reperfusion was denoted as a
return to >80% of baseline perfusion rate by 30 min after tPA administration. At a dose of 5
mg/kg i.v., tPA decreases BBB permeability in both young adult and aged rats 24 h after
embolic MCAO (DiNapoli VA et al., 2008). Furthermore, a recent study from our lab utilizing
EEIIMD (a hexapeptide that binds non-thrombolytic sites on tPA) provides evidence that while
some cortical damage could be due to non-thrombolytic actions of tPA; largely, striatal and total
stroke volume are not exacerbated by tPA (Tan et al., 2009).
Functional Testing
At 24 h following MCAO, functional testing was performed using the modified Neurological
Severity Scores (mNSS), which is a composite score of motor, sensory, balance and reflex
measures ranging from 1-17, with higher scores indicating greater neurological injury(Chen J et
al., 2001).
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Determination of Infarct Volume and Edema Formation
At 24 h following MCAO, rats (n=6) were anesthetized with ketamine and xylazine, sacrificed by
decapitation, brains removed and sliced coronally at 2 mm intervals. Sections were incubated in
2% 2,3,5-triphenyltetrazolium chloride (TTC) for 20 min at 37ºC. Following TTC staining, infarct
volumes were quantified according to method previously described (Yang ZW et al., 1998a).
For each brain section, ischemic area was outlined and infarct volume calculated. To avoid
overestimation of infarct volume, the corrected infarction volume (CIV) was calculated: CIV=(LA[RA-RI])xd, where LA was area of the left hemisphere (mm2), RA was area of the right
hemisphere (mm2), RI was the infracted area (mm2), and d was slice thickness (2 mm). Edema
index (%) was calculated according to previously described method (Maier et al., 1998). Briefly,
edema index=(RV-LV)/LVx100%, where RV was volume of right hemisphere (mm3) and LV was
volume of left hemisphere (mm3).
Blood-brain barrier (BBB) permeability
At 24 h following MCAO, In situ brain perfusion and capillary depletion were carried out as
described previously (n=6) (Preston JE et al., 1995; Triguero D et al., 1990). Briefly, rats were
anesthetized with ketamine (90 mg/kg; i.p.) and xylazine (5 mg/kg; i.p.) and heparinized (10,000
U/kg; i.p.). The common carotid arteries were exposed, cannulated and perfused with modified
Krebs-Henseleit Ringer’s (117 mmol/L NaCl; 4.7 mmol/L KCl; 0.8 mmol/L MgSO4; 24.8 mmol/L
NaHCO3; 1.2 mmol/L KH2PO4; 2.5 mmol/L CaCl2; 10mmol/L D-glucose; dextran (70,000 Da) 29
g/L; bovine serum albumin 10 g/L), aerated with 95% O2/5% CO2 and warmed to 37°C. With
start of the perfusion jugular vein was sectioned to allow for drainage. Once both arteries were
cannulated, [14C]-sucrose was infused (flow rate: 0.5 ml/min) into the inflowing Ringer’s solution
(total flow rate: 3.6 ml/min/hemisphere). After 20 min, the brain was flushed for 20 s with
unlabeled Ringer’s solution and the rat sacrificed by decapitation. The brain was removed,
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dissected into ipsilateral and contralateral hemispheres and the choroid plexis and meninges
excised. Brain tissue samples (~150 mg wet weight) and 100 μl of perfusate samples were
prepared for radioactive counting by addition of 1 ml of tissue solubilizer (TS-2; Research
Products Inc.; Mount Prospect, IL). After 72 h in TS-2, 250 μl glacial acetic acid and 4 ml
scintillation cocktail (Bio-Safe NA; Research Products Inc.) were added and samples analyzed
by liquid scintillation counting (Beckman LS5801; Beckman Coulter; Fullerton, CA). Amount of
[14C] radioactivity in the brain (Ctissue; dpm/g) was expressed as a percentage of that in artificial
perfusate (Cperfusate; dpm/ml) and termed Rtissue% (µl/g) as follows: Rtissue% = (Ctissue / Cperfusate) x
100%.
Capillary depletion was carried out after in situ perfusion, the brain was removed dissected into
ipsilateral and contralateral hemispheres and choroid plexis and meninges excised.
Hemispheres were homogenized in 1.5 ml capillary depletion buffer (4-[2-hydroxyethyl]-1piperazineethanesulfonic acid (HEPES); 141 mM NaCl; 4 mM KCl; 2.8 mM CaCl2; 1 mM
MgSO4; 1 mM NaH2PO4; 10 mM D-glucose; pH 7.4) maintained at 4ºC. An equal volume of icecold 26% dextran (60,000 Da) solution was added to homogenate. Aliquots of homogenate
were taken and centrifuged at 5,400 x g for 15 min. Capillary depleted supernatant was
separated from the vascular pellet. Homogenate, supernatant, and resuspended vascular pellet
were assayed for radioactivity using a liquid scintillation counter.
Markers of oxidative stress
At 24 h following MCAO, rats (n=6) were anesthetized with ketamine and xylazine and
transcardially perfused with 0.9% saline with heparin (2 U/ml). Brains were removed, and the
ipsilateral and contralateral hemispheres separated. Brain sections were weighed and stored at
-

80°C. Measurement of superoxide dismutase (SOD), glutathione peroxidase (GPx), and

catalase (CAT) activities as well as, thiobarbituric acid reactive substances (TBARS) in the form
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of malondialdehyde (MDA) and protein carbonyl were carried out according to manufacturer’s
protocols(Cayman Chemicals; Ann Arbor, MI).
Statistics
Data are presented as mean ± S.E. BBB permeability and oxidative stress assays were
compared by three-way (ANOVA) with Tukey’s post hoc analysis. Functional score, stroke
infarct volume and edema formation were compared by two-way ANOVA with Tukey’s post hoc
analysis. Statistical significance was set at p<0.05.
RESULTS
A total of 92 young adult and 120 aged rats were used in this study. At 24 h following MCAO,
apocynin treatment led to increased mortality in aged rats from 14% (7 of 51) to 36% (25 of 69).
Vehicle-treated aged rats suffered higher mortality than young adult rats (6%; 3 of 45). In young
adult rats, treatment with apocynin (10%; 5 of 47) had no effect on mortality. No rats were
excluded from the study for not meeting the criteria for ischemic depth and reperfusion. No
deleterious signs of hemorrhage from tPA use were observed in the study. These findings were
consistent with prior studies showing that administration of tPA at 5 mg/kg at 2 h after start of
vessel occlusion did not worsen and, in fact, improved infarct volume compared to ischemic
injury following suture occlusion and reperfusion (DiNapoli VA et al., 2006; DiNapoli VA et al.,
2008;Tan et al., 2009).
Functional Score
At 24 h following MCAO, neurological function was assessed using a modified mNSS (Figure
3.1). Aged rats (11±1) suffered worsened functional outcome compared to young adult rats
(8±0.5). While apocynin improved functional outcome in young adult rats (5±1), no
improvement from apocynin was noted in aged rats (10±0.5).
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Stroke Volume
At 24 h following MCAO, cortical, striatal and total stroke infarct volumes were calculated from
TTC stained brain sections (Figure 3.2 A-C). Apocynin-treated aged rats displayed no
improvement compared to vehicle-treated aged rats in cortical (27±4% and 21±4%,
respectively), striatal (62±7% and 80±5%, respectively) or total (33±3% and 31±3%,
respectively) stroke volumes. Aged rats exhibited significantly worsened cortical (21±4% and
10±2%, respectively) and total (31±1% and 19±2%, respectively) stroke volumes compared to
young adult rats. Treatment with apocynin significantly decreased striatal (33±10% and 72±7%,
respectively) and total (6±2% and 19±2%, respectively) stroke volume in young adult rats
compared to vehicle-treated young adult rats.
Edema Formation
At 24 h following MCAO, edema formation was measured (Figure 3.2D). Apocynin treated aged
rats (20±2%) had exacerbated edema as compared to vehicle-treated aged rats (6±3%). No
difference in edema formation between young adult, young adult apocynin treated, and aged
rats was observed.
BBB Permeability
At 24 h following MCAO, BBB permeability was measured utilizing a 20 min in situ brain
perfusion with [14C]sucrose (Figure 3.3). Aged rats treated with apocynin showed no difference
in BBB permeability compared to vehicle-treated aged rats. The ipsilateral hemisphere of aged
rats (4.2±0.2%) showed increased permeability of [14C]sucrose compared to both young adult
MCAO rats (2.9±0.4%) and aged sham rats (2.0±0.1%). Following MCAO, aged rats also
demonstrated increased permeability to [14C]sucrose in the contralateral hemisphere (2.9±0.2%)
as compared to aged sham rats (2.0±0.1%). The ipsilateral hemisphere of young rats
(2.9±0.4%) exhibited increased permeability of [14C]sucrose as compared to young adult sham
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rats (1.6±0.1%). When treated with apocynin 30 min prior to MCAO, young adult rats exhibited
attenuated BBB permeability (2.0±0.2%).
Enzyme activity
At 24 h following MCAO, aged rats treated with apocynin showed reduced SOD activity
compared to respective young adult rats (Figure 3.4). Following MCAO, young adult rats had
reduced GPx in the contralateral hemisphere (321±66 nmol/min/ml) compared to young adult
sham rats (471±36 nmol/min/ml). Treatment with apocynin in young adult rats reduced GPx in
the ipsilateral hemisphere (205±55 nmol/min/ml and 605±57 nmol/min/ml respectively), and
GPx (138±35 nmol/min/ml and 321±68, respectively) and CAT (71±0.6 mmol/min/ml and
115±15 mmol/min/ml, respectively) in the contralateral hemisphere compared to vehicle-treated
young adult rats. When compared to young adult sham rats, aged sham rats had decreased
SOD (805±80 U/ml and 388±82 U/ml respectively) and GPx (471±36 nmol/min/ml and 348±66
nmol/min/ml respectively).
Oxidative Damage
At 24 h following MCAO, lipid peroxidation was assessed by measurement of its byproduct,
MDA (Figure 3.5A). No significant difference was found between sham and MCAO rats.
Apocynin treatment significantly decreased MDA concentration in aged rats as compared to
aged sham rats.
Protein oxidation was measured by assessment of protein carbonyl content (Figure 5B).
In aged rats, apocynin treatment significantly increased protein carbonyl content in the
ipsilateral (13±1 nmol/mg) and contralateral (11±2 nmol/mg) hemispheres as compared to aged
sham rats (6±1 nmol/mg). Aged rats showed significantly higher protein carbonyl content in the
contralateral hemisphere post MCAO (11±2 nmol/mg) than aged sham rats (6±1 nmol/mg).
When treated with apocynin there was a significant increase in protein carbonyl content in
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young adult rats in both the ipsilateral (10±0.5 nmol/mg and 7±1 nmol/mg, respectively) and
contralateral (8±1 nmol/mg and 6±0.7 nmol/mg, respectively) hemispheres as compared to
young adult vehicle-treated rats. At 24 h following MCAO, young adult vehicle-treated rats
showed no change in protein carbonyl content as compared to sham rats.
DISCUSSION
The primary finding of this study was that inhibition of the NOX2 isoform of NADPH oxidase
prior to MCAO elicited distinctly different brain injuries between young adult and aged rats. We
report, for the first time, that treatment with apocynin prior to MCAO in aged rats resulted in
increased mortality at 24 h with no improvement in total or regional infarct volume, edema
formation, or functional outcome. We showed that at 24 h following MCAO, both ipsilateral and
contralateral hemispheres of aged rats had increased BBB permeability to sucrose (342 Da)
and apocynin treatment did not improve BBB functional integrity. Often in stroke studies
utilizing young animals, the contralateral hemisphere is either ignored or considered control.
However, previous clinical studies have observed changes in the contralateral hemisphere
following stroke (Carey et al., 2002; Blank et al., 2003). In addition to changes in BBB
permeability in the contralateral hemisphere, significant changes in catalase activity, GPx
activity, and protein carbonyl content after MCAO were found. This study, in correlation with
others (Buga et al., 2008; Carey et al., 2002; Blank et al., 2003), highlights a potential role for
the contralateral hemisphere as a compensatory mechanism following stroke. Utilizing aged
rodents in stroke models provides a unique opportunity to gain a better understanding of
changes in the contralateral hemisphere following stroke.
Our study confirmed the findings of previous studies that in young adult rats, NOX2
inhibition with apocynin prior to MCAO significantly improved total stroke volume and functional
outcome. We demonstrated that much of the improvement in brain injury in young adult rats
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following MCAO was due to improved striatal infarct volume, lessened edema formation, and
decreased BBB disruption. Understanding the effects of ischemic brain injury in reproductively
senescent females is an understudied yet important area of research as females have an
increased overall stroke burden (Lloyd-Jones et al., 2009). Recent studies indicate that gender
plays a role in some mechanistic pathways following brain injury and recovery after stroke (De
Silva et al., 2009; McCullough LD et al., 2005). Our current results argue against genderrelated differences in NADPH oxidase activity, as results obtained from young adult female rats
in our study were comparable to young adult male rats used in previous studies (Tang et al.,
2007;Tang et al., 2008;Yenari MA et al., 2006;Kahles T et al., 2007); however, further
investigation will need to be done to ascertain if these findings hold true in aged rats.
The decreased SOD and GPx activity observed in aged rats supports the “free radical
theory of aging”, which contends that age-related diseases result from increased generation of
reactive oxygen species (Harman D, 1994) and decreased antioxidant enzyme activity (Azhar S
et al., 1995; Abete P et al., 1999). However, in concurrence with other studies (Meng et al.,
2007; Goto et al., 1999), catalase activity and protein oxidation were unchanged due to the
aging process. The brain, having a high metabolic rate and lack of metabolic reserves,
possesses an increased concentration of mitochondria compared to other organs. Thus the
brain is more resistant to lipid peroxidation (Meyer et al., 2004), perhaps due to break down of
MDA by mitochondrial aldehyde dehydrogenase (Siu and Draper, 1982). Hypoxia and brain
injury show elevated MDA, however, this increase is only seen at early time points, between 1
and 3 h (Lo W et al., 2007; Wang Q et al., 2006; Pantke et al., 1999). Due to the early formation
and stability of protein carbonyl (Pantke et al., 1999), we propose that it is a better indicator than
TBARS of oxidative damage in the brain at 24h after MCAO.
Inhibition of NOX2 with apocynin has recently gained momentum as a therapeutic option
for treatment of acute ischemic stroke (Tang et al., 2007; Wang Q et al., 2006; Kahles T et al.,
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2007) as several studies demonstrate that administration of apocynin (5-50 mg/kg; i.p.) in young
rodents prior to MCAO attenuated superoxide production, infarct volume (Tang et al., 2007),
neuronal death, activated microglia (Wang Q et al., 2006) and edema formation (Kahles T et al.,
2007). Interestingly though, route of administration may play a role in apocynin toxicity as a
recent study reported that when apocynin (5 mg/kg) was administered intravenously prior to
MCAO, rodents exhibited larger cerebral hemorrhages in both hemispheres and increased
mortality (Tang et al., 2008). These opposing findings suggest that the activation, mechanism
of action, and toxicity of apocynin are still poorly understood and further studies are necessary,
especially before any therapeutic use of NOX2 inhibition is pursued in clinical trials.
In this study, young adult apocynin-treated rats exhibited decreased GPx activity and
increased protein oxidation after MCAO and reperfusion, possibly as a consequence of
unactivated apocynin, which acts as a pro-oxidant by decreasing the glutathione to glutathione
disulfide ratio (Riganti et al., 2006). Unactivated apocynin promotes hydrogen peroxide
production and increases protein carbonyl formation (Riganti et al., 2006; Ciolino and Levine,
1997). Unactivated apocynin must be activated to inhibit NOX2 (Stefanska and Pawliczak,
2008). Activation of apocynin by myeloperoxidase (MPO) forms an apocynin dimer, which
prevents recruitment of the cytosolic proteins and thereby inhibits NADPH oxidase activation
(Stefanska and Pawliczak, 2008). In pathologic inflammatory conditions MPO is elevated
(Tsimikas, 2008). In particular, aged animals exhibit exacerbated inflammatory cell infiltration
(DiNapoli VA et al., 2008) and worsened stroke volume which produces increased MPO
expression (Romanos et al., 2007). The positive correlation between MPO expression and
apocynin activation suggests enhanced NOX2 inhibition with age. Data gathered from young
animals suggest that increased NOX2 inhibition results in a favorable outcome. In direct
contrast, our data show that aged rats exhibit exacerbated edema formation and increased
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mortality. We conclude that inhibition of NOX2 with apocynin exacerbates stroke injury in the
aged rat and would be a poor choice for clinical treatment of stroke.
Results from models utilizing aged animals are increasingly divergent from those in
young adult animals. Evidence collected from aged animal models (DiNapoli VA et al., 2008;
DiNapoli VA et al., 2006; Badan I et al., 2003; Popa-Wagner et al., 2007; Schroeder E et al.,
2003) suggests that, in addition to exacerbated brain injury and persistent functional deficit after
stroke, changes are occurring in the contralateral hemisphere. Disregarding the aging process
in stroke research may be an important and yet overlooked mechanism resulting in failure to
produce clinically applicable therapies.
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Figure 3.1: Functional Outcome was measured utilizing the modified Neurological Severity
Score (mNSS). Values are expressed as mean ± SEM (n=42). Statistical significance was
determined as * p < 0.05 as compared to vehicle treated MCAO young adult rats and # p < 0.05
compared to apocynin treated young adult rats using two-way ANOVA with tukey’s post hoc
analysis.
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Figure 3.2: TTC stained brain sections were used to calculate (A) cortical, (B) striatal, and (C)
total stroke volume and (D) edema formation at 24 h following MCAO in vehicle and apocynintreated young adult and aged rats. Bars represent mean ± S.E. (n=6). Statistical significance
was set at *p<0.05 compared to vehicle-treated young adult rats, #p<0.05 as compared to
apocynin-treated young adult rats using two-way ANOVA with Tukey’s post hoc analysis.
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Figure 3.3. At 24 h following MCAO, (A) in situ brain perfusion using [14C]sucrose (342 Da) was
used to determine the degree of BBB permeability and (B) the effect of apocynin treatment on
changes in BBB permeability in young adult and aged rats. Brains were separated into infarcted
and non-infarcted hemispheres. Bars represent mean ± S.E. (n=6). Statistical significance was
set at *p<0.05 compared to vehicle-treated age-matched sham, #p<0.05 compared to
respective hemisphere of the vehicle-treated young adult MCAO rats, ‡p<0.05 compared to the
respective non-infarct hemisphere, and †p<0.05 as compared to apocynin-treated young adult
rats using three-way ANOVA with Tukey’s post hoc analysis.
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Figure 3.4. (A) Superoxide dismutase (SOD), (B) glutathione peroxidase (GPx), and (C)
catalase (CAT) activities were spectrophotometrically measured in infarcted and non-infarcted
hemispheres at 24 h following MCAO in vehicle and apocynin-treated young adult and aged
rats. Bars represent mean ± S.E. (n=6). Statistical significance was set at *p<0.05 compared to
age-matched sham, #p<0.05 compared to vehicle-treated young adult MCAO rats, ‡p<0.05
compared to respective non-infarct hemisphere, †p<0.05 compared to apocynin-treated young
adult rats and §p<0.05 compared to respective young adult group using three-way ANOVA with
Tukey’s post hoc analysis.
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Figure 3.5: Downstream products of lipid peroxidation (A) malondialdehyde (MDA) and (B)
protein carbonyl were spectrophotometrically measured to assess the effect of apocynin
treatment on oxidative stress at 24 h following MCAO in young adult and aged rats. Brains
were separated into infarcted and non-infarcted hemispheres. Bars represent mean ± S.E.
(n=6). Statistical significance was set at *p<0.05 compared to age-matched sham, #p<0.05
compared to vehicle-treated young adult MCAO, and §p<0.05 compared to respective young
adult group using three-way ANOVA with Tukey’s post hoc analysis.
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Chapter Four

NADPH oxidase isoform expression in aged female rats after MCAO
and reperfusion.
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ABSTRACT

NADPH oxidases (NOX) are a family of enzymes that play a role in the aging process,
progression of atherosclerosis, and inflammatory response. However, the role of NOX isoforms
during stroke-related ischemia and reperfusion in aged rats has yet to be elucidated. In this
study, middle cerebral artery occlusion (MCAO) with tissue plasminogen activator (tPA) was
used to assess time-dependent changes in NOX1, NOX2, NOX4, and catalytic subunits
P22PHOX and P47PHOX in aged female rats. Real time (RT) PCR was used to determine
transcriptional regulation of NOX isoforms 2 and 24 h post MCAO and reperfusion. NOX1
transcriptional regulation was decreased in the contralateral hemisphere 24 h after MCAO.
Downregulation of NOX4 24 h after MCAO and reperfusion was found in the ipsilateral cortex.
NOX2 was upregulated at 24 h after stroke and reperfusion, a finding consistent with young
animals. Catyaltic subunit P22PHOX , binds to all NOX isoforms, and is upregulated at 24 h.
Post-ischemia molecular mechanisms in aged rats are poorly understood, which may explain
differences in functional stroke outcomes and failed clinical treatments.
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Introduction
Stroke is a disease of the elderly, yet most preclinical studies have been conducted in young
rodents. Evidence suggests that altered NOX expression may play a role in the aging process
(Krause, 2007; Geiszt et al., 2000; Park L et al., 2007). NOX2 containing NADPH oxidases are
a damaging source of reactive oxygen species during the aging process (Park L et al., 2007;
Hamilton CA et al., 2001) and progression of ischemic damage (Walder et al., 1997; Wang Q et
al., 2006). Several studies demonstrate that inhibition of NOX2 with apocynin in young rodents
prior to MCAO attenuated superoxide production, infarct volume (Tang et al., 2007), neuronal
death, activated microglia (Wang Q et al., 2006) and edema formation(Kahles T et al., 2007). In
contrast, inhibition of NOX2 with apocynin in aged animals caused increased edema and
mortality 24 h after middle cerebral artery occlusion (MCAO) with tissue plasminogen activator
(tPA) reperfusion (Kelly et al., 2009).
Several isoforms of NADPH oxidases are expressed in vascular cells. While NOX2 is
widely considered the predominant isoform, it is the least expressed isoform in the brain
vasculature. In the brain vasculature, NADPH oxidase isoform expression varies with NOX1
being the most abundant, followed by NOX4 and lastly NOX2 (Ago et al., 2005). As NOX1 and
NOX4 have yet to be extensively studied, their roles are not yet fully understood. After cerebral
ischemia, NOX1 knockout mice had greater cortical infarct volume when compared to wild type
mice (Jackman et al., 2009), suggesting that NOX1 may play a neuroprotective role in stroke
progression. Following ischemic stroke and reperfusion, expression of NOX4 is increased at
early time points but after reperfusion returns to baseline levels (McCann SK et al., 2008),
possibly impacting reperfusion injury. The relationship between NOX isoform expression,
ischemia and age has yet to be determined. This study utilized MCAO with tPA reperfusion in
aged rats to assess the differences in expression of NOX isoforms.
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Methods
MCAO
Female Sprague-Dawley rats aged 18-20 months (275-350 g) were received from Harlan
(Indianapolis, IN) and housed under natural light/dark conditions with food and water available
ad libitum. Procedures involving animals abided by the West Virginia University Animal Care
and Use Committee. Rats were anesthetized with 2% isoflurane (Webster Veterinary). Rats
underwent MCAO for 2 h followed by tPA (Genentech; San Francisco, CA)-induced reperfusion
as previously described (DiNapoli VA et al., 2006). Briefly, a micro-catheter was inserted into
the internal carotid artery (ICA) and advanced until its tip occluded the ipsilateral MCA. This
mechanical occlusion was verified by laser Doppler (LD-CBF) monitoring of the cerebral blood
flow in the MCA perfusion territory. A 25 mm fibrin-rich, autologous blood clot was then injected
directly into the MCA. Cerebral blood flow (CBF) was monitored continuously. After 2 h of
ischemia, tPA (5 mg/kg) was administered via the femoral vein, and restoration of blood flow
through the MCA was verified by LD-CBF. Ischemia was defined as a perfusion drop across the
MCA territory of >80% as determined by laser Doppler and successful reperfusion was denoted
as a return to >80% of baseline perfusion rate by 30 min after tPA administration. Animals not
meeting this criteria were excluded from analysis.

Microvessel Isolation
At 2 and 24 h after MCAO rats were anesthetized with ketamine (90 mg/kg; i.p.) and
xylazine (5 mg/kg; i.p.) and transcardially perfused with 0.9% saline. Brains were
removed and microvessel isolations were performed as previously described (VanGilder
et al., 2009). Briefly, brains were separated into ipsilateral and contralateral
hemispheres and the meninges and choroid plexus removed. Samples of cortex (0.75
g) and striatum (0.75 g) were taken for RNA and protein extraction. The remaining
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cortex was homogenized in 2 ml microvessel isolation buffer (MVI1; 103 mM NaCl;
4.7mM KCl; 2.5 mM KH2PO4; 1.2 mM MgSO4; 15 mM HEPES; 2.5 mM NaHCO3; 10 mM
D-glucose; 1 mM Na pyruvate; 10 g/l dextran (64,000 Da)) with protease inhibitor
cocktail (PIC; 1:1000). Dextran (26%) was added and the homogenate was centrifuged
at 4°C for 10 min at 5,800 x g. The supernatant was aspirated and the pellet
resuspended in 2.5 ml of a second microvessel isolation buffer (MVI2; 103 mM NaCl;
4.7 mM KCl; 2.5 mM CaCl2; 1.2 mM KH2PO4; 1.2 mM MgSO4; 15 mM HEPES). The
homogenate was then filtered through a 100 μm filter and centrifuged at 4°C for 5 min at
5,800 x g. The supernatant was decanted and the microvessel pellet used for RNA
extraction.
Real Time – Polymerase Chain Reaction (RT-PCR)
Total RNA was isolated from cerebral microvessels (n=4) using TriReagent®.
Concentration of RNA was determined and only considered for use if A260/A280 was
≥1.80. Total RNA was reverse transcribed into cDNA using a 20 µl reaction. RT-PCR
analyses of NOX1, NOX2, NOX4, p22phox, and p47phox using a StepOne™ detection
system (Applied Biosystems; Foster City, CA) in combination with TaqMan® chemistry.
Specific primers and dual labeled internal (FAM/TAMRA) probe sets were used
according to manufacturer’s recommendation (Applied Biosystems). All PCR
amplifications were run in a 20 µl reaction volume consisting of 1µl cDNA.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as control to
normalize for differences in amount of cDNA added to reactions. Negative controls
were monitored simultaneously within each run. Thermocycling conditions were set to
holding stage at 50° C for 2 min and 95°C for 10 min and 40 cycles of 95° C for 15 s
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and 60° C for 1 min. According to manufacturer’s instructions, relative quantification of
mRNA transcripts was carried out using the comparative threshold (ΔΔCT) method.
Statistics
Data for mRNA are presented as ΔΔCT and was compared by one-way (ANOVA) with Tukey’s
post hoc analysis. Statistical significance was set at p<0.05.
Results
RT-PCR analysis of NOX1 was performed at 2 h after MCAO and 24 h after MCAO and
reperfusion (Figure 4.1). NOX1 transcription was decreased 24 h after MCAO and reperfusion
in the contralateral hemisphere of the cortex (1.7 fold; p=0.05) and striatum (2.3 fold; p=0.025)
as compared to aged matched sham rats.
RT-PCR analysis of NOX4 was performed at 2 h after MCAO and 24 h after MCAO and
reperfusion (Figure 4.2). Transcription of NOX4 was decreased 2 fold in the ipsilateral
hemisphere of the cortex at 24 h post-MCAO and reperfusion (p=0.006) as compared to aged
matched sham rats.
At 2 and 24 h after MCAO and reperfusion RT-PCR analysis of NOX2 (Figure 4.3)
revealed significant increases in transcription after 24 h in the ipsilateral hemisphere. In the
cerebral microvessels of the ipsilateral hemisphere NOX2 transcription was increased 4 fold as
compared to aged matched sham rats (p=0.012). NOX2 transcription was increased 3 fold in
the ipsilateral hemisphere of the striatum (p=0.003) as compared to aged matched sham rats.
The transcription of the P22PHOX membrane bound subunit of NADPH oxidase was
measured by RT-PCR 2 and 24 h after MCAO and reperfusion (Figure 4.4). In the ipsilateral
hemisphere, transcription of P22PHOX was increased 2 fold in the cerebral microvessels
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(p=0.05), 2.4 fold in the cortex (p=0.018), and 2.7 fold in the striatum (p=0.011) as compared to
age matched sham rats.
Finally, P47PHOX transcription was measured by RT-PCR at 2 and 24 h after MCAO
and reperfusion (figure 4.5). In the contralateral hemisphere at 2 h, P47PHOX transcription was
decreased 2.4 fold (p=0.01) as compared to age matched sham rats.
Discussion
The primary finding of this study is that although the NOX2 isoform and P22PHOX subunit are
increased at 24 h post-MCAO and reperfusion, conversely the NOX4 and NOX1 isoforms
exhibit either unchanged or decreased transcription at both time points studied.
Without selective inhibitors of NOX1, its direct effect on stroke outcome is poorly
understood. One study using NOX1 knockout mice found that cortical infarct volume was four
fold greater in young adult NOX1 knockout mice when compared to wild type mice with 30 min
MCAO and 23.5 h reperfusion (Jackman et al., 2009). As NOX1 may play a potentially
beneficial role in stroke outcome, the decreased mRNA expression found in the cortex and
striatum of the contralateral hemisphere of aged rats could explain the greater stroke damage
found in aged rats after MCAO and reperfusion.
In young adult animals NOX4 mRNA is increased at 24 h after permanent cerebral
ischemia peaking between 7 and 15 days in the ischemic hemisphere (Vallet P et al., 2005). In
contrast, a model of MCAO and reperfusion found increased NOX4 mRNA expression as early
as 6 h after MCAO with a return to baseline within 24 h (McCann SK et al., 2008), indicating a
clear difference in NOX4 expression depending on reperfusion. Interestingly,
immunohistochemical analysis of NOX4 at 7 days post-MCAO revealed the location of the
NOX4 expression to be in the new capillaries (Vallet P et al., 2005). There was a trend towards
increased NOX4 expression in the ipsilateral cortex at 2 h after MCAO and significantly
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decreased expression at 24 h indicating a similar sequence of NOX4 regulation after MCAO as
Vallet et al., 2005. This suggests that age does not play a significant role in transcriptional
regulation of NOX4 after MCAO and reperfusion.
Tumor necrosis factor alpha (TNFα) has been shown to increase activity of NOX4
(Basuroy et al., 2008;Jung Y et al., 2008;Chenevier-Gobeaux et al., 2006). After MCAO, TNFα
is increased as early as 1 h (Wang et al., 1994) and progressing out to several days and even
weeks in humans (Sairanen et al., 2001). TNFα quickly activates NOX4 suggesting posttranslational mechanism of the increased activity (Basuroy et al., 2008). As TNFα expression is
increased in aged animals as compared to young adult animals after stroke (DiNapoli,
unpublished data) it is possible that NOX4 activity but not translation is increased in aged
animals after MCAO and reperfusion.
Increased mRNA expression of NOX2 was found in both the ipsilateral cortex and
striatum of young adult animals 24 h post MCAO and reperfusion (McCann SK et al., 2008). In
mice with dysfunctional NOX2 transient focal ischemia resulted in decreased infarct volume
than wild type mice (Walder et al., 1997). Age has been shown to increase superoxide
production by NOX2 causing impaired endothelium dependent relaxation and functional
hyperemia (park L et al., 2007). Inhibition of NOX2 with apocynin has recently gained
momentum as a therapeutic option for treatment of acute ischemic stroke (Tang et al., 2007;
Wang Q et al., 2006; Kahles T et al., 2007) as studies demonstrate that administration of
apocynin (5-50 mg/kg; i.p.) in young rodents prior to MCAO, attenuated superoxide production,
infarct volume (Tang et al., 2007), neuronal death, activation of microglia (Wang Q et al., 2006)
and edema formation (Kahles T et al., 2007). In direct contrast, our data show that aged rats
exhibit exacerbated edema formation and increased mortality (Kelly et al., 2009). The present
study found increased NOX2 mRNA expression not only in the striatum, where most of the
stroke damage if found, but also in the cerebral microvasculature.
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P22PHOX is a membrane bound subunit of NADPH oxidase. The NOX1, NOX2 and
NOX4 isoforms of NADPH oxidase all bind to P22PHOX at the plasma membrane (Bedard K
and Krause K, 2007;Clempus and Griendling, 2006). NADPH oxidase activity has been linked
to transcription changes in P22PHOX (Manea et al., 2007). The present study found increased
P22PHOX mRNA expression throughout the ipsilateral hemisphere in aged rats 24 h after
MCAO and reperfusion. This suggests that activity of NOX1, NOX2 and NOX4 may be
increased as they all bind to P22PHOX.
In conclusion, the direct affects of NOX1 and NOX4 activity after MCAO in aged animals
need to be elucidated. The present data suggest that NOX1 transcriptional regulation is altered
with age, which may exacerbate stroke damage. Transcriptional regulation of NOX2 and NOX4
mimic that seen in young adult animals, however since the present study did not measure
activity of these enzymes, post-transcriptional modification could play a role. Changes in the
contralateral hemisphere support recent evidence (Kelly et al., 2009; Buga et al., 2008; Carey et
al., 2002; Blank et al., 2003) that investigation of changes in the contralateral hemisphere is
important and understudied in stroke research.
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Figure 4.1. NOX1 mRNA from sham, 2 h MCAO, and 24 h MCAO and reperfusion rats was
measured by real-time PCR. Samples were taken from isolated microvessels (A and B), cortex
(C and D) and striatum (E and F) of the ipsilateral (A, C and E) and contralateral (B, D, and F)
hemispheres. Data are expressed as ΔΔCT.
79

Figure 4.2. NOX4 mRNA from sham, 2 h MCAO, and 24 h MCAO and reperfusion rats was
measured by real-time PCR. Samples were taken from isolated microvessels (A and B), cortex
(C and D) and striatum (E and F) of the ipsilateral (A, C and E) and contralateral (B, D, and F)
hemispheres. Data are expressed as ΔΔCT.
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Figure 4.3. NOX2 mRNA from sham, 2 h MCAO, and 24 h MCAO and reperfusion rats was
measured by real-time PCR. Samples were taken from isolated microvessels (A and B), cortex
(C and D) and striatum (E and F) of the ipsilateral (A, C and E) and contralateral (B, D, and F)
hemispheres. Data are expressed as ΔΔCT.
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Figure 4.4. P22POX mRNA from sham, 2 h MCAO, and 24 h MCAO and reperfusion rats was
measured by real-time PCR. Samples were taken from isolated microvessels (A and B), cortex
(C and D) and striatum (E and F) of the ipsilateral (A, C and E) and contralateral (B, D, and F)
hemispheres. Data are expressed as ΔΔCT.
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Figure 4.5. P47PHOX mRNA from sham, 2 h MCAO, and 24 h MCAO and reperfusion rats was
measured by real-time PCR. Samples were taken from isolated microvessels (A and B), cortex
(C and D) and striatum (E and F) of the ipsilateral (A, C and E) and contralateral (B, D, and F)
hemispheres. Data are expressed as ΔΔCT.
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